Publications

Publications from OUS - Department of Nephrology Rikshospitalet (Div SIMT)

757 publications found

Publications 2019

  1. Berstad AE, Brabrand K, Horneland R, Syversveen T, Haugaa H, Jenssen TG, Foss A (2019)
    Microbubble contrast-enhanced ultrasound in the vascular evaluation after pancreas transplantation: a single-center experience
    Acta Radiol, 284185119828190 (in press)
    DOI 10.1177/0284185119828190, PubMed 30754980
  2. Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O et al. (2019)
    Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
    Ther Drug Monit, 41 (3), 261-307
    DOI 10.1097/FTD.0000000000000640, PubMed 31045868
  3. Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K (2019)
    Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients
    Transplant Proc, 51 (2), 470-474
    DOI 10.1016/j.transproceed.2019.01.068, PubMed 30879570
  4. Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2019)
    Author Correction: Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Sci Rep, 9 (1), 6347
    DOI 10.1038/s41598-019-42218-6, PubMed 30988313
  5. Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A (2019)
    Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
    Transpl Int, 32 (6), 614-625
    DOI 10.1111/tri.13412, PubMed 30770608
  6. Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Åsberg A, Jenssen T (2019)
    Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
    Diabetes Care, 42 (6), 1067-1074
    DOI 10.2337/dc19-0093, PubMed 30862658
  7. Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
    Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
    Transpl Int (in press)
    DOI 10.1111/tri.13443, PubMed 30983060
  8. Jenssen T, Hartmann A (2019)
    Post-transplant diabetes mellitus in patients with solid organ transplants
    Nat Rev Endocrinol, 15 (3), 172-188
    DOI 10.1038/s41574-018-0137-7, PubMed 30622369
  9. Ju A, Josephson MA, Butt Z, Jowsey-Gregoire S, Tan J, Taylor Q, Fowler K, Dobbels F, Caskey F, Jha V, Locke J, Knoll G, Ahn C, Hanson CS, Sautenet B, Manera K, Craig JC, Howell M, Rutherford C, Tong A, Harden P, Hawley C, Holdaas H, Israni A, Jesse M et al. (2019)
    Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report
    Transplantation, 103 (6), 1199-1205
    DOI 10.1097/TP.0000000000002476, PubMed 30300284
  10. Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
    A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
    Ther Drug Monit, 41 (1), 11-18
    DOI 10.1097/FTD.0000000000000580, PubMed 30633722
  11. Melsom T, Nair V, Schei J, Mariani L, Stefansson VTN, Harder JL, Jenssen TG, Solbu MD, Norvik JV, Looker H, Knowler WC, Kretzler M, Nelson RG, Eriksen BO (2019)
    Correlation Between Baseline GFR and Subsequent Change in GFR in Norwegian Adults Without Diabetes and in Pima Indians
    Am J Kidney Dis, 73 (6), 777-785
    DOI 10.1053/j.ajkd.2018.11.011, PubMed 30704883
  12. Mjoen G, Reisæter A, Hartmann A, Dahle DO, Holdaas H (2019)
    Regarding age-calibrated glomerular filtration rate
    Kidney Int, 95 (1), 234-235
    DOI 10.1016/j.kint.2018.10.003, PubMed 30606421
  13. Thorsen IS, Bleskestad IH, Åsberg A, Hartmann A, Skadberg Ø, Brede C, Ueland T, Pasch A, Reisaeter AV, Gøransson LG (2019)
    Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study
    Clin Transplant, 33 (5), e13517
    DOI 10.1111/ctr.13517, PubMed 30844090
  14. Tunbridge M, Holdaas H, Jardine AG (2019)
    Pulse Pressure: A Risk Factor for Renal Transplant Failure or a Useful Therapeutic Target?
    Transplantation, 103 (4), 662-663
    DOI 10.1097/TP.0000000000002441, PubMed 30188414
  15. Ussif AM, Åsberg A, Halden TAS, Nordheim E, Hartmann A, Jenssen T (2019)
    Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
    BMC Nephrol, 20 (1), 12
    DOI 10.1186/s12882-018-1171-3, PubMed 30630438
  16. von Zur-Mühlen B, Lundgren T, Bayman L, Berne C, Bridges N, Eggerman T, Foss A, Goldstein J, Jenssen T, Jorns C, Morrison Y, Rydén M, Schwieger T, Tufveson G, Nilsson B, Korsgren O (2019)
    Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation
    Transplantation, 103 (3), 630-637
    DOI 10.1097/TP.0000000000002425, PubMed 30211831
  17. Aasebø W, Svensson M, Jenssen T, Eide IA (2019)
    Marine n-3 Polyunsaturated Fatty Acid Supplementation and Quality of Life After Kidney Transplant
    Transplant Proc, 51 (2), 466-469
    DOI 10.1016/j.transproceed.2019.01.067, PubMed 30879569

Publications 2018

  1. Abedini S, Gøransson L, Cockburn E, Kilany S, Holdaas H (2018)
    Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
    Transplant Direct, 4 (2), e338
    DOI 10.1097/TXD.0000000000000755, PubMed 29464199
  2. Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A (2018)
    Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 33 (10), 1794-1804
    DOI 10.1093/ndt/gfx355, PubMed 29361126
  3. Chandra A, Svensson M, Åsberg A, Schmidt EB, Bjerve KS, Jenssen T, Hartmann A, Ueland T, Eide IA (2018)
    Trans-fatty Acids and Survival in Renal Transplantation
    J Ren Nutr, 29 (3), 169-180
    DOI 10.1053/j.jrn.2018.08.003, PubMed 30309780
  4. Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A (2018)
    High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
    Transpl Int, 32 (3), 257-269
    DOI 10.1111/tri.13356, PubMed 30252957
  5. Eide IA, Reinholt FP, Jenssen T, Hartmann A, Schmidt EB, Åsberg A, Bergan S, Brabrand K, Svensson M (2018)
    Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trial
    Am J Transplant, 19 (3), 790-800
    DOI 10.1111/ajt.15080, PubMed 30125457
  6. Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2018)
    Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Sci Rep, 8 (1), 14722
    DOI 10.1038/s41598-018-33189-1, PubMed 30283093
  7. Eriksen BO, Småbrekke S, Jenssen TG, Mathisen UD, Norvik JV, Schei J, Schirmer H, Solbu MD, Stefansson VTN, Melsom T (2018)
    Office and Ambulatory Heart Rate as Predictors of Age-Related Kidney Function Decline
    Hypertension, 72 (3), 594-601
    DOI 10.1161/HYPERTENSIONAHA.118.11594, PubMed 30354758
  8. Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD (2018)
    First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
    Transplant Direct, 4 (7), e366
    DOI 10.1097/TXD.0000000000000802, PubMed 30046656
  9. García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D (2018)
    Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
    Clin Transplant, 32 (3), e13196
    DOI 10.1111/ctr.13196, PubMed 29380890
  10. Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
    Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
    Transpl Int, 31 (6), 629-638
    DOI 10.1111/tri.13137, PubMed 29453878
  11. Heldal TF, Ueland T, Jenssen T, Hartmann A, Reisaeter AV, Aukrust P, Michelsen A, Åsberg A (2018)
    Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study
    Transpl Int, 31 (5), 510-519
    DOI 10.1111/tri.13116, PubMed 29341300
  12. Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V (2018)
    Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry
    Am J Kidney Dis, 73 (2), 184-193
    DOI 10.1053/j.ajkd.2018.05.016, PubMed 30122544
  13. Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
    Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
    Ther Drug Monit, 40 (5), 558-566
    DOI 10.1097/FTD.0000000000000539, PubMed 30086087
  14. Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K (2018)
    Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
    Transplant Direct, 4 (4), e351
    DOI 10.1097/TXD.0000000000000770, PubMed 29707622
  15. Lønning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K (2018)
    Changes in health-related quality of life in older candidates waiting for kidney transplantation
    Nephrology (Carlton), 23 (10), 948-956
    DOI 10.1111/nep.13117, PubMed 28734131
  16. Lønning K, Midtvedt K, Heldal K, Andersen MH (2018)
    Older kidney transplantation candidates' expectations of improvement in life and health following kidney transplantation: semistructured interviews with enlisted dialysis patients aged 65 years and older
    BMJ Open, 8 (6), e021275
    DOI 10.1136/bmjopen-2017-021275, PubMed 29934388
  17. Mafham MM, Staplin N, Emberson J, Haynes R, Herrington W, Reith C, Wanner C, Walker R, Cass A, Levin A, Fellström B, Jiang L, Holdaas H, Kasiske B, Wheeler DC, Landray MJ, Baigent C, SHARP Collaborative Group (2018)
    Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection
    Nephrol Dial Transplant, 33 (2), 257-264
    DOI 10.1093/ndt/gfw396, PubMed 28088776
  18. Majak GB, Reisæter AV, Weedon-Fekjær H, Henriksen T, Michelsen TM (2018)
    The Effect of Pregnancy on the Long-term Risk of Graft Loss, Cardiovascular Disease, and Death in Kidney Transplanted Women in Norway: A Retrospective Cohort Study
    Transplantation, 102 (9), e391-e396
    DOI 10.1097/TP.0000000000002167, PubMed 29528968
  19. Melsom T, Solbu MD, Schei J, Stefansson VTN, Norvik JV, Jenssen TG, Wilsgaard T, Eriksen BO (2018)
    Mild Albuminuria Is a Risk Factor for Faster GFR Decline in the Nondiabetic Population
    Kidney Int Rep, 3 (4), 817-824
    DOI 10.1016/j.ekir.2018.01.015, PubMed 29989017
  20. Mjoen G, Holdaas H (2018)
    Mid- and Long-Term Health Risks in Living Kidney Donors
    Ann Intern Med, 169 (4), 265
    DOI 10.7326/L18-0340, PubMed 30128523
  21. Nordheim E, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen T (2018)
    Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
    Eur J Endocrinol, 179 (4), 251-259
    DOI 10.1530/EJE-18-0360, PubMed 30299895
  22. Nordheim E, Horneland R, Aandahl EM, Grzyb K, Aabakken L, Paulsen V, Midtvedt K, Hartmann A, Jenssen T (2018)
    Pancreas transplant rejection episodes are not revealed by biopsies of the donor duodenum in a prospective study with paired biopsies
    Am J Transplant, 18 (5), 1256-1261
    DOI 10.1111/ajt.14658, PubMed 29316221
  23. Pedersen HL, Horvei KD, Thiyagarajan D, Norby GE, Seredkina N, Moroni G, Eilertsen GØ, Holdaas H, Strøm EH, Bakland G, Meroni PL, Rekvig OP (2018)
    Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression
    J Pathol Clin Res, 4 (3), 193-203
    DOI 10.1002/cjp2.99, PubMed 29624903
  24. Pihlstrøm HK, Mjøen G, Mucha S, Franke A, Jardine A, Fellström B, Dahle DO, Holdaas H, Melum E (2018)
    Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
    Am J Transplant, 19 (5), 1444-1451
    DOI 10.1111/ajt.15191, PubMed 30457209
  25. Pippias M, Stel VS, Kramer A, Abad Diez JM, Aresté-Fosalba N, Ayav C, Buturovic J, Caskey FJ, Collart F, Couchoud C, De Meester J, Heaf JG, Helanterä I, Hemmelder MH, Kostopoulou M, Noordzij M, Pascual J, Palsson R, Reisaeter AV, Traynor JP, Massy Z, Jager KJ (2018)
    Access to kidney transplantation in European adults aged 75-84 years and related outcomes: an analysis of the European Renal Association-European Dialysis and Transplant Association Registry
    Transpl Int, 31 (5), 540-553
    DOI 10.1111/tri.13125, PubMed 29383764
  26. Skaare H, Svensson M, Jenssen T, Åsberg A, Schmidt EB, Chandra A, Ueland T, Mollnes TE, Hartmann A, Eide IA (2018)
    Plasma n-6 Polyunsaturated Fatty Acid Levels and Survival in Renal Transplantation
    J Ren Nutr, 28 (5), 333-339
    DOI 10.1053/j.jrn.2018.02.008, PubMed 29703632
  27. Solbu MD, Kolset SO, Jenssen TG, Wilsgaard T, Løchen ML, Mathiesen EB, Melsom T, Eriksen BO, Reine TM (2018)
    Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromsø Study
    Atherosclerosis, 278, 166-173
    DOI 10.1016/j.atherosclerosis.2018.08.005, PubMed 30278359
  28. Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2018)
    Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
    Nephrol Dial Transplant, 33 (1), 102-112
    DOI 10.1093/ndt/gfw360, PubMed 27798199
  29. Stefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO (2018)
    Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population
    Kidney Int, 93 (5), 1183-1190
    DOI 10.1016/j.kint.2017.11.012, PubMed 29395334
  30. Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ (2018)
    International comparison of trends in patients commencing renal replacement therapy by primary renal disease
    Nephrology (Carlton) (in press)
    DOI 10.1111/nep.13531, PubMed 30456883
  31. Tronstad C, Elvebakk O, Staal OM, Kalvøy H, Høgetveit JO, Jenssen TG, Birkeland KI, Martinsen ØG (2018)
    Non-invasive prediction of blood glucose trends during hypoglycemia
    Anal Chim Acta, 1052, 37-48
    DOI 10.1016/j.aca.2018.12.009, PubMed 30685040
  32. Urstad KH, Wahl AK, Engebretsen E, Larsen MH, Vidnes TK, Stenwig AGK, Simensen ØW, Nordli A, Reisaeter AV, Andersen MH (2018)
    Implementation of a new patient education programme for renal transplant recipients
    J Ren Care, 44 (2), 106-114
    DOI 10.1111/jorc.12236, PubMed 29460501
  33. Ussif A, Pihlstrøm H, Pasch A, Holdaas H, Hartmann A, Smerud K, Åsberg A (2018)
    Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
    BMC Nephrol, 19 (1), 212
    DOI 10.1186/s12882-018-1000-8, PubMed 30134956
  34. von Düring ME, Jenssen T, Bollerslev J, Godang K, Hartmann A, Åsberg A (2018)
    Arterial stiffness is associated with visceral fat mass in kidney transplanted patients-A nationwide cohort study
    Clin Transplant, 32 (8), e13341
    DOI 10.1111/ctr.13341, PubMed 29957825

Publications 2017

  1. Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM, NAVIGATOR Study Group (2017)
    Updated risk factors should be used to predict development of diabetes
    J Diabetes Complications, 31 (5), 859-863
    DOI 10.1016/j.jdiacomp.2017.02.012, PubMed 28319004
  2. Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017)
    NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation
    Br J Clin Pharmacol, 83 (11), 2494-2502
    DOI 10.1111/bcp.13367, PubMed 28686294
  3. Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
    Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
    Transplantation, 101 (10), 2599-2605
    DOI 10.1097/TP.0000000000001659, PubMed 28207636
  4. de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M, ELEVATE Study Group (2017)
    Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial
    Am J Transplant, 17 (7), 1853-1867
    DOI 10.1111/ajt.14186, PubMed 28027625
  5. Dupont L, Eide IA, Hartmann A, Christensen JH, Åsberg A, Jenssen T, Krarup H, Svensson M (2017)
    Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
    Prog Transplant, 27 (4), 386-391
    DOI 10.1177/1526924817732020, PubMed 29187131
  6. Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
    High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
    Transplantation, 101 (8), e273-e279
    DOI 10.1097/TP.0000000000001796, PubMed 28452920
  7. Eide IA, Dörje C, Svensson M, Jenssen T, Hammarstrøm C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Åsberg A, Reisæter AV, Reinholt FP (2017)
    Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
    J Ren Nutr, 28 (2), 118-124
    DOI 10.1053/j.jrn.2017.09.001, PubMed 29146138
  8. Eide IA, Halden TAS, Hartmann A, Dahle DO, Åsberg A, Jenssen T (2017)
    Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
    Transplantation, 101 (6), 1282-1289
    DOI 10.1097/TP.0000000000001259, PubMed 27362306
  9. Eriksen BO, Stefansson VT, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2017)
    Blood pressure and age-related GFR decline in the general population
    BMC Nephrol, 18 (1), 77
    DOI 10.1186/s12882-017-0496-7, PubMed 28245797
  10. Eriksen BO, Stefansson VTN, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2017)
    High Ambulatory Arterial Stiffness Index Is an Independent Risk Factor for Rapid Age-Related Glomerular Filtration Rate Decline in the General Middle-Aged Population
    Hypertension, 69 (4), 651-659
    DOI 10.1161/HYPERTENSIONAHA.117.09020, PubMed 28223468
  11. García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV (2017)
    Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
    Transplantation, 101 (6), 1410-1415
    DOI 10.1097/TP.0000000000001216, PubMed 27163535
  12. Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
    Should patients older than 65 years be offered a second kidney transplant?
    BMC Nephrol, 18 (1), 13
    DOI 10.1186/s12882-016-0426-0, PubMed 28077080
  13. Holdaas H, Mjøen G, Jardine AG (2017)
    Belatacept: Where the BENEFITS Outweigh the Risk
    Am J Kidney Dis, 69 (5), 561-563
    DOI 10.1053/j.ajkd.2017.02.007, PubMed 28434523
  14. Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
    Recovery of CYP3A Phenotype after Kidney Transplantation
    Drug Metab Dispos, 45 (12), 1260-1265
    DOI 10.1124/dmd.117.078030, PubMed 28928137
  15. Jenssen T, Hartmann A, Birkeland KI (2017)
    Long-term diabetes complications after pancreas transplantation
    Curr Opin Organ Transplant, 22 (4), 382-388
    DOI 10.1097/MOT.0000000000000436, PubMed 28598888
  16. Koefoed-Nielsen P, Weinreich I, Bengtsson M, Lauronen J, Naper C, Gäbel M, Sørensen SS, Wennberg L, Reisaeter AV, Møller BK, Nordic Kidney group and the Tissue Typing group in Scandiatransplant (2017)
    Scandiatransplant acceptable mismatch program (STAMP) a bridge to transplanting highly immunized patients
    HLA, 90 (1), 17-24
    DOI 10.1111/tan.13046, PubMed 28449350
  17. Lindahl JP, Horneland R, Nordheim E, Hartmann A, Aandahl EM, Grzyb K, Haugaa H, Kjøsen G, Åsberg A, Jenssen T (2017)
    Outcomes in Pancreas Transplantation With Exocrine Drainage Through a Duodenoduodenostomy Versus Duodenojejunostomy
    Am J Transplant, 18 (1), 154-162
    DOI 10.1111/ajt.14420, PubMed 28696022
  18. Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2017)
    Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
    Transplantation, 101 (6), 1261-1267
    DOI 10.1097/TP.0000000000001274, PubMed 27467687
  19. Majak GB, Reisæter AV, Zucknick M, Lorentzen B, Vangen S, Henriksen T, Michelsen TM (2017)
    Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system
    PLoS One, 12 (3), e0173420
    DOI 10.1371/journal.pone.0173420, PubMed 28319175
  20. Meyer KB, Hartmann A, Mjøen G, Andersen MH (2017)
    Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
    Ann Transplant, 22, 148-155
    DOI 10.12659/aot.902330, PubMed 28321111
  21. Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
    Exposure to Mycophenolate and Fatherhood
    Transplantation, 101 (7), e214-e217
    DOI 10.1097/TP.0000000000001747, PubMed 28346297
  22. Midtvedt K, Åsberg A (2017)
    Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
    Transplantation, 101 (1), e39
    DOI 10.1097/TP.0000000000001509, PubMed 27748704
  23. Mjøen G, Holdaas H (2017)
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors"
    Kidney Int, 91 (5), 1256
    DOI 10.1016/j.kint.2017.01.034, PubMed 28407879
  24. Mjøen G, Holdaas H (2017)
    Long term risk of mortality after living kidney donation
    BMJ, 357, j1770
    DOI 10.1136/bmj.j1770, PubMed 28442509
  25. Norby GE, Mjøen G, Bjørneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarød K (2017)
    Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry
    Lupus, 26 (8), 881-885
    DOI 10.1177/0961203316686700, PubMed 28059018
  26. Norvik JV, Schirmer H, Ytrehus K, Jenssen TG, Zykova SN, Eggen AE, Eriksen BO, Solbu MD (2017)
    Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromso Study
    BMC Cardiovasc. Disord., 17, 79
  27. Norvik JV, Schirmer H, Ytrehus K, Storhaug HM, Jenssen TG, Eriksen BO, Mathiesen EB, Løchen ML, Wilsgaard T, Solbu MD (2017)
    Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013
    ESC Heart Fail, 4 (2), 154-161
    DOI 10.1002/ehf2.12134, PubMed 28451452
  28. Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
    Transpl Int, 30 (8), 827-840
    DOI 10.1111/tri.12973, PubMed 28436117
  29. Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS (2017)
    Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association-European Dialysis and Transplant Association Registry
    Transpl Int, 31 (7), 708-719
    DOI 10.1111/tri.13103, PubMed 29210108
  30. Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
    Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
    PLoS Pathog, 13 (4), e1006299
    DOI 10.1371/journal.ppat.1006299, PubMed 28406982
  31. Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
    Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
    PLoS Pathog, 13 (5), e1006386
    DOI 10.1371/journal.ppat.1006386, PubMed 28489893
  32. Salvador CL, Hartmann A, Åsberg A, Bergan S, Rowe AD, Mørkrid L (2017)
    Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
    Transplant Direct, 3 (12), e332
    DOI 10.1097/TXD.0000000000000742, PubMed 29536033
  33. Schei J, Fuskevåg OM, Stefansson VTN, Solbu MD, Jenssen TG, Eriksen BO, Melsom T (2017)
    Urinary Markers of Oxidative Stress Are Associated With Albuminuria But Not GFR Decline
    Kidney Int Rep, 3 (3), 573-582
    DOI 10.1016/j.ekir.2017.11.020, PubMed 29854964
  34. Smerud KT, Åsberg A, Kile H, Pasch A, Dahle DO, Bollerslev J, Godang K, Hartmann A (2017)
    A rapid and sustained improvement of calcification propensity score (serum T50 ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
    Clin Transplant, 31 (12)
    DOI 10.1111/ctr.13131, PubMed 28972673
  35. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
    Br J Clin Pharmacol, 83 (7), 1457-1465
    DOI 10.1111/bcp.13248, PubMed 28146606
  36. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'
    Br J Clin Pharmacol, 83 (6), 1357-1358
    DOI 10.1111/bcp.13276, PubMed 28374426
  37. Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D (2017)
    Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants
    Transpl Int, 30 (11), 1119-1131
    DOI 10.1111/tri.13002, PubMed 28667664
  38. van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ (2017)
    Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 32 (2), 348-355
    DOI 10.1093/ndt/gfw392, PubMed 28031344
  39. Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J et al. (2017)
    Standardization of pediatric uroradiological terms: A multidisciplinary European glossary
    J Pediatr Urol, 13 (6), 641-650
    DOI 10.1016/j.jpurol.2017.05.026, PubMed 29174378
  40. Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J et al. (2017)
    Standardization of pediatric uroradiological terms: a multidisciplinary European glossary
    Pediatr Radiol, 48 (2), 291-303
    DOI 10.1007/s00247-017-4006-7, PubMed 29138893
  41. Wagner S, Apetrii M, Massy ZA, Kleber ME, Delgado GE, Scharnagel H, März W, Metzger M, Rossignol P, Jardine A, Holdaas H, Fellström B, Schmieder R, Stengel B, Zannad F, on behalf AURORA study group and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) network (2017)
    Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis
    Free Radic Res, 51 (1), 14-23
    DOI 10.1080/10715762.2016.1241878, PubMed 27667446
  42. Åsberg A, Robertsen I, Midtvedt K (2017)
    How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients
    Transplantation, 101 (11), e347
    DOI 10.1097/TP.0000000000001894, PubMed 28787310

Publications 2016

  1. Cholesterol Treatment Trialists' (CTT) Collaboration, Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C (2016)
    Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
    Lancet Diabetes Endocrinol, 4 (10), 829-39
    DOI 10.1016/S2213-8587(16)30156-5, PubMed 27477773
  2. Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
    Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
    Clin Transplant, 30 (7), 802-9
    DOI 10.1111/ctr.12753, PubMed 27101801
  3. Eide IA, Dahle DO, Svensson M, Hartmann A, Åsberg A, Bjerve KS, Christensen JH, Schmidt EB, Lauritsen ME, Lund K, Jenssen T (2016)
    Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients
    Eur J Clin Nutr, 70 (7), 824-30
    DOI 10.1038/ejcn.2016.14, PubMed 26931669
  4. Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisaeter AV, Jenssen T (2016)
    Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
    Transpl Int, 29 (5), 568-78
    DOI 10.1111/tri.12757, PubMed 26875590
  5. Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2016)
    Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
    J Ren Nutr, 27 (3), 161-168
    DOI 10.1053/j.jrn.2016.09.008, PubMed 27838193
  6. Eriksen BO, Stefansson VTN, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2016)
    Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population
    Kidney Int, 90 (2), 404-410
    DOI 10.1016/j.kint.2016.03.021, PubMed 27188503
  7. Gagnum V, Stene LC, Jenssen TG, Berteussen LM, Sandvik L, Joner G, Njølstad PR, Skrivarhaug T (2016)
    Causes of death in childhood-onset Type 1 diabetes: long-term follow-up
    Diabet Med, 34 (1), 56-63
    DOI 10.1111/dme.13114, PubMed 26996105
  8. Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
    GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
    Diabetes Care, 39 (4), 617-24
    DOI 10.2337/dc15-2383, PubMed 26908914
  9. Holdaas H, De Simone P, Zuckermann A (2016)
    Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
    J Transplant, 2016, 4369574
    DOI 10.1155/2016/4369574, PubMed 27807479
  10. Jørgensen HS, Eide IA, Hartmann A, Åsberg A, Christensen JH, Schmidt EB, Godang K, Bollerslev J, Svensson M (2016)
    Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
    J Ren Nutr, 26 (3), 196-203
    DOI 10.1053/j.jrn.2015.11.007, PubMed 26776249
  11. Kolseth IB, Reine TM, Parker K, Sudworth A, Witczak BJ, Jenssen TG, Kolset SO (2016)
    Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy
    J Diabetes Complications, 31 (1), 245-252
    DOI 10.1016/j.jdiacomp.2016.06.029, PubMed 27452162
  12. Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K (2016)
    Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
    Transplantation, 100 (12), 2705-2709
    DOI 10.1097/TP.0000000000001363, PubMed 27861296
  13. Majak GB, Sandven I, Lorentzen B, Vangen S, Reisaeter AV, Henriksen T, Michelsen TM (2016)
    Pregnancy outcomes following maternal kidney transplantation: a national cohort study
    Acta Obstet Gynecol Scand, 95 (10), 1153-61
    DOI 10.1111/aogs.12937, PubMed 27288648
  14. Melsom T, Stefansson V, Schei J, Solbu M, Jenssen T, Wilsgaard T, Eriksen BO (2016)
    Association of Increasing GFR with Change in Albuminuria in the General Population
    Clin J Am Soc Nephrol, 11 (12), 2186-2194
    DOI 10.2215/CJN.04940516, PubMed 27683625
  15. Meyer K, Wahl AK, Bjørk IT, Wisløff T, Hartmann A, Andersen MH (2016)
    Long-term, self-reported health outcomes in kidney donors
    BMC Nephrol, 17, 8
    DOI 10.1186/s12882-016-0221-y, PubMed 26754798
  16. Miroslawska AK, Gjessing PF, Solbu MD, Fuskevåg OM, Jenssen TG, Steigen TK (2016)
    Renal Denervation for Resistant Hypertension Fails to Improve Insulin Resistance as Assessed by Hyperinsulinemic-Euglycemic Step Clamp
    Diabetes, 65 (8), 2164-8
    DOI 10.2337/db16-0205, PubMed 27246911
  17. Mjoen G, Reisaeter AV, Dahle DO (2016)
    HLA Mismatch and Allograft Survival
    Transplantation, 100 (9), e52
    DOI 10.1097/TP.0000000000001366, PubMed 27399204
  18. Mjøen G, Holdaas H (2016)
    Regarding long-term outcome after kidney donation
    Transpl Int, 29 (3), 381
    DOI 10.1111/tri.12717, PubMed 26563683
  19. Mjøen G, Holdaas H (2016)
    Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
    N Engl J Med, 374 (21), 2094
    DOI 10.1056/NEJMc1603007, PubMed 27223156
  20. Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 31 (1), 170
    DOI 10.1093/ndt/gfv397, PubMed 26740671
  21. Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A (2016)
    Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
    Transplant Direct, 2 (11), e113
    DOI 10.1097/TXD.0000000000000627, PubMed 27826606
  22. Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, Solbu MD (2016)
    Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study
    BMC Cardiovasc Disord, 16, 85
    DOI 10.1186/s12872-016-0265-8, PubMed 27165776
  23. Pihlstrøm HK, Mjøen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellström B, Holdaas H, Melum E (2016)
    Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study
    Am J Transplant, 17 (2), 528-533
    DOI 10.1111/ajt.13995, PubMed 27483393
  24. Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ (2016)
    Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry
    Transplantation, 100 (9), 1955-62
    DOI 10.1097/TP.0000000000000962, PubMed 26588008
  25. Reine TM, Jenssen TG, Kolset SO (2016)
    Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro
    Food Nutr Res, 60, 32615
    DOI 10.3402/fnr.v60.32615, PubMed 27667774
  26. Schive SW, Foss A, Sahraoui A, Kloster-Jensen K, Hafsahl G, Kvalheim G, Lundgren T, von Zur-Mühlen B, Felldin M, Rafael E, Lempinen M, Korsgren O, Jenssen TG, Mishra V, Scholz H (2016)
    Cost and clinical outcome of islet transplantation in Norway 2010-2015
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12871, PubMed 27862341
  27. Skrunes R, Svarstad E, Reisæter AV, Marti HP, Vikse BE (2016)
    End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population
    PLoS One, 11 (11), e0165026
    DOI 10.1371/journal.pone.0165026, PubMed 27828975
  28. Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
    Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
    BMC Nephrol, 17 (1), 148
    DOI 10.1186/s12882-016-0373-9, PubMed 27760523
  29. Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
    Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
    Am J Transplant, 17 (1), 265-271
    DOI 10.1111/ajt.13933, PubMed 27341702
  30. Solbu MD, Norvik JV, Storhaug HM, Eriksen BO, Melsom T, Eggen AE, Zykova SN, Kronborg JB, Jenssen TG (2016)
    The Association Between Adiponectin, Serum Uric Acid and Urinary Markers of Renal Damage in the General Population: Cross-Sectional Data from the Tromsø Study
    Kidney Blood Press Res, 41 (5), 623-634
    DOI 10.1159/000447931, PubMed 27622764
  31. Stefansson VT, Schei J, Jenssen TG, Melsom T, Eriksen BO (2016)
    Central obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional study
    BMC Nephrol, 17 (1), 172
    DOI 10.1186/s12882-016-0386-4, PubMed 27832768
  32. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2016)
    Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
    Br J Clin Pharmacol, 83 (6), 1350-1352
    DOI 10.1111/bcp.13188, PubMed 28008657
  33. Størset E, von Düring ME, Godang K, Bergan S, Midtvedt K, Åsberg A (2016)
    Prediction of Fat-Free Mass in Kidney Transplant Recipients
    Ther Drug Monit, 38 (4), 439-46
    DOI 10.1097/FTD.0000000000000305, PubMed 27019101
  34. Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
    Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
    Nephrology (Carlton), 21 (10), 821-7
    DOI 10.1111/nep.12738, PubMed 26854648
  35. von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Hartmann A (2016)
    Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12869, PubMed 27859633

Publications 2015

  1. Breckenridge K, Bekker HL, Gibbons E, van der Veer SN, Abbott D, Briançon S, Cullen R, Garneata L, Jager KJ, Lønning K, Metcalfe W, Morton RL, Murtagh FE, Prutz K, Robertson S, Rychlik I, Schon S, Sharp L, Speyer E, Tentori F, Caskey FJ (2015)
    How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting
    Nephrol Dial Transplant, 30 (10), 1605-14
    DOI 10.1093/ndt/gfv209, PubMed 25982327
  2. Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
    Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
    Transplantation, 99 (8), 1730-7
    DOI 10.1097/TP.0000000000000660, PubMed 25757216
  3. Dahle DO, Åsberg A, Hartmann A, Holdaas H, Bachtler M, Jenssen TG, Dionisi M, Pasch A (2015)
    Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients
    Am J Transplant, 16 (1), 204-12
    DOI 10.1111/ajt.13443, PubMed 26375609
  4. Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H (2015)
    Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study
    Transplantation, 99 (7), 1470-6
    DOI 10.1097/TP.0000000000000568, PubMed 25675199
  5. Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
    One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
    Clin Transplant, 29 (3), 268-76
    DOI 10.1111/ctr.12515, PubMed 25644963
  6. Egli A, Lisboa LF, O'Shea D, Asberg A, Mueller T, Emery V, Kumar D, Humar A (2015)
    Complexity of Host Micro-RNA Response to Cytomegalovirus Reactivation After Organ Transplantation
    Am J Transplant, 16 (2), 650-60
    DOI 10.1111/ajt.13464, PubMed 26460801
  7. Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisæter AV, Jenssen T (2015)
    Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus
    Transplantation, 99 (3), 629-35
    DOI 10.1097/TP.0000000000000376, PubMed 25162478
  8. Eide IA, Halden TA, Jenssen T (2015)
    The Authors' Reply: HbA1c Is Insensitive at Month 3 After Kidney Transplantation
    Transplantation, 99 (5), e38
    DOI 10.1097/TP.0000000000000684, PubMed 25943237
  9. Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
    Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival
    Nephrol Dial Transplant, 31 (1), 160-7
    DOI 10.1093/ndt/gfv339, PubMed 26410884
  10. Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
    The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation
    Clin J Am Soc Nephrol, 10 (7), 1246-56
    DOI 10.2215/CJN.11931214, PubMed 26063768
  11. Eriksen BO, Løchen ML, Arntzen KA, Bertelsen G, Winther Eilertsen BA, von Hanno T, Herder M, Jenssen TG, Mathisen UD, Melsom T, Njølstad I, Solbu MD, Mathiesen EB (2015)
    Estimated and Measured GFR Associate Differently with Retinal Vasculopathy in the General Population
    Nephron, 131 (3), 175-84
    DOI 10.1159/000441092, PubMed 26426198
  12. Jenssen T, Hartmann A (2015)
    Emerging treatments for post-transplantation diabetes mellitus
    Nat Rev Nephrol, 11 (8), 465-77
    DOI 10.1038/nrneph.2015.59, PubMed 25917553
  13. Kolseth IB, Reine TM, Vuong TT, Meen AJ, Fan Q, Jenssen TG, Grønning-Wang LM, Kolset SO (2015)
    Serglycin is part of the secretory repertoire of LPS-activated monocytes
    Immun Inflamm Dis, 3 (1), 23-31
    DOI 10.1002/iid3.47, PubMed 25866637
  14. Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2015)
    Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
    Diabetologia, 59 (4), 844-52
    DOI 10.1007/s00125-015-3853-8, PubMed 26713324
  15. Lisboa LF, Egli A, O'Shea D, Åsberg A, Hartmann A, Rollag H, Pang XL, Tyrrell DL, Kumar D, Humar A (2015)
    Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications
    Am J Transplant, 15 (7), 1893-902
    DOI 10.1111/ajt.13222, PubMed 25833298
  16. Meen AJ, Drevon CA, Pejler G, Jenssen TG, Olstad OK, Åbrink M, Kolset SO (2015)
    Serglycin protects against high fat diet-induced increase in serum LDL in mice
    Glycoconj J, 32 (9), 703-14
    DOI 10.1007/s10719-015-9621-7, PubMed 26391682
  17. Melsom T, Fuskevåg OM, Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO (2015)
    Estimated GFR is biased by non-traditional cardiovascular risk factors
    Am J Nephrol, 41 (1), 7-15
    DOI 10.1159/000371557, PubMed 25612475
  18. Melsom T, Schei J, Stefansson VT, Solbu MD, Jenssen TG, Mathisen UD, Wilsgaard T, Eriksen BO (2015)
    Prediabetes and Risk of Glomerular Hyperfiltration and Albuminuria in the General Nondiabetic Population: A Prospective Cohort Study
    Am J Kidney Dis, 67 (6), 841-50
    DOI 10.1053/j.ajkd.2015.10.025, PubMed 26744126
  19. Mjøen G, Holdaas H (2015)
    The authors reply:
    Kidney Int, 87 (3), 660
    DOI 10.1038/ki.2014.400, PubMed 25723634
  20. Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S (2015)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial
    Clin Transplant, 29 (8), 678-84
    DOI 10.1111/ctr.12565, PubMed 25982053
  21. Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV (2015)
    Regional differences in renal replacement therapy in northern Norway 2000-2012
    Int J Circumpolar Health, 74 (1), 24298
    DOI 10.3402/ijch.v74.24298, PubMed 28417823
  22. Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV (2015)
    Regional differences in renal replacement therapy in northern Norway 2000-2012
    Int J Circumpolar Health, 74, 24298
    DOI 10.3402/ijch.v74.24298, PubMed 25672881
  23. Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H (2015)
    Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism
    Transplantation, 99 (2), 351-9
    DOI 10.1097/TP.0000000000000583, PubMed 25594550
  24. Reine TM, Vuong TT, Rutkovskiy A, Meen AJ, Vaage J, Jenssen TG, Kolset SO (2015)
    Serglycin in Quiescent and Proliferating Primary Endothelial Cells
    PLoS One, 10 (12), e0145584
    DOI 10.1371/journal.pone.0145584, PubMed 26694746
  25. Robertsen I, Vethe NT, Midtvedt K, Falck P, Christensen H, Åsberg A (2015)
    Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood Concentrations
    Ther Drug Monit, 37 (5), 675-80
    DOI 10.1097/FTD.0000000000000185, PubMed 25565673
  26. Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
    Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
    Transplantation, 99 (3), 528-32
    DOI 10.1097/TP.0000000000000384, PubMed 25148382
  27. Schive SW, Scholz H, Sahraoui A, Kloster-Jensen K, Hafsahl G, Korsgren O, Foss A, Jenssen TG (2015)
    Graft function 1 year after pregnancy in an islet-transplanted patient
    Transpl Int, 28 (10), 1235-9
    DOI 10.1111/tri.12596, PubMed 25903157
  28. Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
    High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
    Transplantation, 99 (4), 791-6
    DOI 10.1097/TP.0000000000000422, PubMed 25222012
  29. Solbu MD, Toft I, Løchen ML, Mathiesen EB, Eriksen BO, Melsom T, Njølstad I, Wilsgaard T, Jenssen TG (2015)
    N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
    J Am Soc Nephrol, 27 (2), 533-42
    DOI 10.1681/ASN.2014100960, PubMed 26047791
  30. Sriskandarajah S, Aasarød K, Skrede S, Knoop T, Reisæter AV, Bjørneklett R (2015)
    Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies
    Nephrol Dial Transplant, 30 Suppl 1, i67-75
    DOI 10.1093/ndt/gfv008, PubMed 25694535
  31. Storhaug HM, Toft I, Norvik JV, Jenssen T, Eriksen BO, Melsom T, Løchen ML, Solbu MD (2015)
    Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study
    BMC Nephrol, 16, 210
    DOI 10.1186/s12882-015-0207-1, PubMed 26651613
  32. Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
    Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
    Transplantation, 99 (10), 2158-66
    DOI 10.1097/TP.0000000000000708, PubMed 25886918
  33. Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P (2015)
    Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
    Transplantation, 99 (1), 100-5
    DOI 10.1097/TP.0000000000000227, PubMed 24983306
  34. von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Eide IA, Dahle DO, Hartmann A (2015)
    Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
    Transpl Int, 28 (10), 1162-71
    DOI 10.1111/tri.12606, PubMed 25970153
  35. Vuong TT, Reine TM, Sudworth A, Jenssen TG, Kolset SO (2015)
    Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healing
    J Histochem Cytochem, 63 (4), 280-92
    DOI 10.1369/0022155415568995, PubMed 25575567
  36. Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I (2015)
    Impact of initial dialysis modality on mortality: a propensity-matched study
    BMC Nephrol, 16, 179
    DOI 10.1186/s12882-015-0175-5, PubMed 26519164
  37. Zykova SN, Storhaug HM, Toft I, Chadban SJ, Jenssen TG, White SL (2015)
    Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromsø study
    Nutr J, 14, 49
    DOI 10.1186/s12937-015-0032-1, PubMed 25971955

Publications 2014

  1. Apeland T, Holdaas H, Mansoor MA (2014)
    Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer capacity
    Clin Biochem, 47 (6), 378-82
    DOI 10.1016/j.clinbiochem.2014.02.003, PubMed 24530370
  2. Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
    Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
    Ann Rheum Dis, 74 (8), 1515-21
    DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010
  3. Beitland S, Os I, Sunde K (2014)
    Primary injuries and secondary organ failures in trauma patients with acute kidney injury treated with continuous renal replacement therapy
    Scientifica (Cairo), 2014, 235215
    DOI 10.1155/2014/235215, PubMed 25587490
  4. Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Gøransson LG (2014)
    Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function
    Clin Transplant, 28 (4), 479-86
    DOI 10.1111/ctr.12341, PubMed 25649861
  5. Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Weimar W, Hesselink DA, Van Gelder T (2014)
    Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients
    Clin Transplant, 28 (6), 649-55
    DOI 10.1111/ctr.12346, PubMed 24579958
  6. Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
    Uric acid and clinical correlates of endothelial function in kidney transplant recipients
    Clin Transplant, 28 (10), 1167-76
    DOI 10.1111/ctr.12435, PubMed 25124959
  7. Dörje C, Midtvedt K, Reisæter AV (2014)
    Analysis of predictive and preventive factors for de novo donor-specific antibodies in kidney transplant recipientsy--is nonadherence of importance?
    Transplantation, 98 (4), e31
    DOI 10.1097/TP.0000000000000330, PubMed 25243517
  8. Hirsch HH, Babel N, Comoli P, Friman V, Ginevri F, Jardine A, Lautenschlager I, Legendre C, Midtvedt K, Muñoz P, Randhawa P, Rinaldo CH, Wieszek A, ESCMID Study Group of Infection in Compromised Hosts (2014)
    European perspective on human polyomavirus infection, replication and disease in solid organ transplantation
    Clin Microbiol Infect, 20 Suppl 7, 74-88
    DOI 10.1111/1469-0691.12538, PubMed 24476010
  9. Holdaas H, Jardine AG (2014)
    BP targets in renal transplant recipients: too high or too low?
    J Am Soc Nephrol, 25 (7), 1371-3
    DOI 10.1681/ASN.2014020177, PubMed 24627350
  10. Holdaas H, Mjoen G (2014)
    Long-term risks of kidney donation: age known
    Am J Transplant, 14 (11), 2671-2
    DOI 10.1111/ajt.12971, PubMed 25293790
  11. Holdaas H, Potena L, Saliba F (2014)
    mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern?
    Transplant Rev (Orlando), 29 (2), 93-102
    DOI 10.1016/j.trre.2014.08.003, PubMed 25227328
  12. Horneland R, Paulsen V, Lindahl JP, Grzyb K, Eide TJ, Lundin K, Aabakken L, Jenssen T, Aandahl EM, Foss A, Øyen O (2014)
    Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges--but offers improved endoscopic access for scheduled biopsies and therapeutic interventions
    Am J Transplant, 15 (1), 242-50
    DOI 10.1111/ajt.12953, PubMed 25394773
  13. Lindahl JP, Jenssen T, Hartmann A (2014)
    Long-term outcomes after organ transplantation in diabetic end-stage renal disease
    Diabetes Res Clin Pract, 105 (1), 14-21
    DOI 10.1016/j.diabres.2014.03.004, PubMed 24698407
  14. Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Øyen O, Brabrand K, Jenssen T (2014)
    In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
    Diabetologia, 57 (11), 2357-65
    DOI 10.1007/s00125-014-3353-2, PubMed 25145544
  15. Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
    The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
    Eur J Clin Pharmacol, 70 (6), 685-93
    DOI 10.1007/s00228-014-1656-3, PubMed 24658827
  16. Midtvedt K, Heldal K (2014)
    Chronic kidney disease and the aging population
    Transplantation, 97 (11), e64
    DOI 10.1097/TP.0000000000000172, PubMed 24887750
  17. Mjøen G (2014)
    The author replies
    Kidney Int, 85 (6), 1469
    DOI 10.1038/ki.2014.91, PubMed 24875550
  18. Mjøen G, Hallan S, Dekker FW, Holdaas H (2014)
    The authors reply
    Kidney Int, 86 (3), 650
    DOI 10.1038/ki.2014.148, PubMed 25168504
  19. Mjøen G, Hallan S, Holdaas H (2014)
    The authors reply:
    Kidney Int, 85 (5), 1241-2
    DOI 10.1038/ki.2014.37, PubMed 24786884
  20. Mjøen G, Holdaas H (2014)
    The authors reply
    Kidney Int, 86 (2), 447
    DOI 10.1038/ki.2014.149, PubMed 25079028
  21. Mjøen G, Holdaas H (2014)
    Selecting appropriate controls for kidney donors
    Am J Transplant, 15 (1), 286
    DOI 10.1111/ajt.13016, PubMed 25363214
  22. Mjörnstedt L, Schwartz Sørensen S, von Zur Mühlen B, Jespersen B, Hansen JM, Bistrup C, Andersson H, Gustafsson B, Solbu D, Holdaas H (2014)
    Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
    Transpl Int, 28 (1), 42-51
    DOI 10.1111/tri.12437, PubMed 25176389
  23. Murbraech K, Holdaas H, Massey R, Undset LH, Aakhus S (2014)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial
    Transplantation, 97 (2), 184-8
    DOI 10.1097/TP.0b013e3182a92728, PubMed 24092385
  24. Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
    Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
    Transplantation, 98 (11), 1219-25
    DOI 10.1097/TP.0000000000000205, PubMed 24999963
  25. Reine TM, Kolseth IB, Meen AJ, Lindahl JP, Jenssen TG, Reinholt FP, Zaia J, Shao C, Hartmann A, Kolset SO (2014)
    Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation
    Diabetes Res Clin Pract, 107 (1), 46-53
    DOI 10.1016/j.diabres.2014.10.006, PubMed 25467621
  26. Reine TM, Vuong TT, Jenssen TG, Kolset SO (2014)
    Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro
    Biochim Biophys Acta, 1840 (8), 2498-505
    DOI 10.1016/j.bbagen.2014.02.002, PubMed 24513305
  27. Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
    More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
    Transplantation, 97 (12), 1266-71
    DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776
  28. Sharif A, Hecking M, de Vries AP, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, Marchetti P, Pacini G, Ojo A, Takahara S, Larsen JL, Budde K, Eller K, Pascual J, Jardine A, Bakker SJ, Valderhaug TG, Jenssen TG, Cohney S, Säemann MD (2014)
    Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions
    Am J Transplant, 14 (9), 1992-2000
    DOI 10.1111/ajt.12850, PubMed 25307034
  29. Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014)
    Familial clustering of ESRD in the Norwegian population
    Clin J Am Soc Nephrol, 9 (10), 1692-700
    DOI 10.2215/CJN.01680214, PubMed 25092600
  30. Strøm Halden TA, Åsberg A, Vik K, Hartmann A, Jenssen T (2014)
    Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
    Nephrol Dial Transplant, 29 (4), 926-33
    DOI 10.1093/ndt/gft536, PubMed 24452849
  31. Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
    Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
    Br J Clin Pharmacol, 78 (3), 509-23
    DOI 10.1111/bcp.12361, PubMed 25279405
  32. von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I (2014)
    From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life
    BMC Nephrol, 15, 191
    DOI 10.1186/1471-2369-15-191, PubMed 25465066
  33. von der Lippe N, Waldum B, Østhus TB, Reisæter AV, Os I (2014)
    Health related quality of life in patients in dialysis after renal graft loss and effect of gender
    BMC Womens Health, 14 (1), 34
    DOI 10.1186/1472-6874-14-34, PubMed 24580724

Publications 2013

  1. Berdal M, Jenssen T (2013)
    No Association between Glycemia and Wound Healing in an Experimental db/db Mouse Model
    ISRN Endocrinol, 2013, 307925
    DOI 10.1155/2013/307925, PubMed 24251043
  2. Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM (2013)
    A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
    Am J Cardiol, 112 (2), 231-7
    DOI 10.1016/j.amjcard.2013.03.019, PubMed 23608615
  3. Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
    Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
    Clin Transplant, 28 (1), 134-40
    DOI 10.1111/ctr.12290, PubMed 24372653
  4. Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
    Endothelial dysfunction is associated with graft loss in renal transplant recipients
    Transplantation, 95 (5), 733-9
    DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481
  5. Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
    Early versus late acute antibody-mediated rejection in renal transplant recipients
    Transplantation, 96 (1), 79-84
    DOI 10.1097/TP.0b013e31829434d4, PubMed 23632391
  6. Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li H, Korth-Bradley JM, Tai SS, Schulman SL (2013)
    A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients
    Transplantation, 95 (10), 1233-41
    DOI 10.1097/TP.0b013e318291a269, PubMed 23689085
  7. Heldal K, Midtvedt K (2013)
    Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens
    Drugs Aging, 30 (7), 459-66
    DOI 10.1007/s40266-013-0082-z, PubMed 23609876
  8. Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
    Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
    Transplant Res, 2 (1), 11
    DOI 10.1186/2047-1440-2-11, PubMed 23799993
  9. Hornum M, Lindahl JP, von Zur-Mühlen B, Jenssen T, Feldt-Rasmussen B (2013)
    Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies
    Transpl Int, 26 (11), 1049-60
    DOI 10.1111/tri.12112, PubMed 23634804
  10. Jenssen T (2013)
    [The body's own signaling system--now as treatment]
    Tidsskr Nor Laegeforen, 133 (23-24), 2447
    DOI 10.4045/tidsskr.13.1434, PubMed 24326489
  11. Knoop T, Vikse BE, Svarstad E, Leh S, Reisæter AV, Bjørneklett R (2013)
    Mortality in patients with IgA nephropathy
    Am J Kidney Dis, 62 (5), 883-90
    DOI 10.1053/j.ajkd.2013.04.019, PubMed 23796906
  12. Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
    Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
    Diabetologia, 56 (6), 1364-71
    DOI 10.1007/s00125-013-2888-y, PubMed 23549518
  13. Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
    Long-term risks for kidney donors
    Kidney Int, 86 (1), 162-7
    DOI 10.1038/ki.2013.460, PubMed 24284516
  14. Pihlstrøm H, Mjøen G, März W, Olav Dahle D, Abedini S, Holme I, Fellström B, Jardine A, Pilz S, Holdaaas H (2013)
    Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
    Clin Transplant, 28 (1), 111-9
    DOI 10.1111/ctr.12285, PubMed 24372612
  15. Reine TM, Grøndahl F, Jenssen TG, Hadler-Olsen E, Prydz K, Kolset SO (2013)
    Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice
    J Histochem Cytochem, 61 (8), 606-16
    DOI 10.1369/0022155413494392, PubMed 23757342
  16. Reine TM, Kusche-Gullberg M, Feta A, Jenssen T, Kolset SO (2013)
    Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells (vol 29, pg 67, 2012)
    Glycoconjugate J., 30 (7), 733
  17. Schjelderup P, Dahle DO, Holdaas H, Mjøen G, Nordby G, Abedini S, Jardine A, Fellström B, Svensson M (2013)
    Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study
    Clin Transplant, 27 (6), E636-43
    DOI 10.1111/ctr.12220, PubMed 23991916
  18. Schneider A, Jardine AG, Schneider MP, Holdaas H, Holme I, Fellstroem BC, Zannad F, Schmieder RE, AURORA Study Group (2013)
    Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study
    Am J Nephrol, 37 (2), 144-51
    DOI 10.1159/000346710, PubMed 23392089
  19. Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
    The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
    Clin Transplant, 28 (1), 120-6
    DOI 10.1111/ctr.12288, PubMed 24351078
  20. Soveri I, Snyder J, Holdaas H, Holme I, Jardine AG, L'Italien GJ, Fellström B (2013)
    The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials
    Transplantation, 95 (1), 142-7
    DOI 10.1097/TP.0b013e31827722c9, PubMed 23192156
  21. Storhaug HM, Norvik JV, Toft I, Eriksen BO, Løchen ML, Zykova S, Solbu M, White S, Chadban S, Jenssen T (2013)
    Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study
    BMC Cardiovasc Disord, 13, 115
    DOI 10.1186/1471-2261-13-115, PubMed 24330812
  22. Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
    Importance of hematocrit for a tacrolimus target concentration strategy
    Eur J Clin Pharmacol, 70 (1), 65-77
    DOI 10.1007/s00228-013-1584-7, PubMed 24071959
  23. Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
    Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
    Clin Transplant, 27 (2), E151-6
    DOI 10.1111/ctr.12076, PubMed 23351013
  24. Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
    Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
    Transpl Int, 26 (12), 1198-207
    DOI 10.1111/tri.12194, PubMed 24118301

Publications 2012

  1. Bleskestad IH, Bergrem H, Hartmann A, Godang K, Gøransson LG (2012)
    Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
    BMC Nephrol, 13, 49
    DOI 10.1186/1471-2369-13-49, PubMed 22742720
  2. Brabrand K, Midtvedt K, Günther A, Marthinsen PB, Berstad AE (2012)
    Color Doppler ultrasound-guided transducer compression of post biopsy bleeding of kidney transplants
    J Clin Ultrasound, 41 (1), 26-31
    DOI 10.1002/jcu.21983, PubMed 22927091
  3. Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A (2012)
    Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy
    J Clin Virol, 54 (1), 56-60
    DOI 10.1016/j.jcv.2012.01.015, PubMed 22410132
  4. Feldman RD, Flack J, Howes L, Jenssen T, Reeves R, Shi H, Westergaard M, Hobbs FD, GEMINI US, GEMINI AALA, JEWEL 1 and 2 and CAPABLE investigators (2012)
    Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis
    Curr Med Res Opin, 28 (9), 1421-33
    DOI 10.1185/03007995.2012.713339, PubMed 22809114
  5. Friberg AS, Lundgren T, Malm H, Felldin M, Nilsson B, Jenssen T, Kyllönen L, Tufveson G, Tibell A, Korsgren O (2012)
    Transplanted functional islet mass: donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients
    Transplantation, 93 (6), 632-8
    DOI 10.1097/TP.0b013e3182455912, PubMed 22258287
  6. Gjersvik P, Helsing P, Holdaas H, Bergan S (2012)
    [Immunosuppressive drugs and the development of skin cancer after organ transplantation]
    Tidsskr Nor Laegeforen, 132 (18), 2064-8
    DOI 10.4045/tidsskr.12.0389, PubMed 23038197
  7. Hartmann A, Jenssen T, Holdaas H (2012)
    Diabetes, chronic kidney disease and cancer risk
    Nephrol Dial Transplant, 27 (8), 3018-20
    DOI 10.1093/ndt/gfs175, PubMed 22734106
  8. Hausken J, Klingenberg O, Mørkrid L, Rollag H, Foss A, Midtvedt K (2012)
    Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation
    Transplantation, 94 (2), e15-6
    DOI 10.1097/TP.0b013e31825b7633, PubMed 22820562
  9. Heldal K, Midtvedt K (2012)
    Doctor, should I remain on dialysis or accept the ECD kidney offered to me?
    Am J Kidney Dis, 59 (6), 748-50
    DOI 10.1053/j.ajkd.2012.03.002, PubMed 22613394
  10. Holdaas H, Jardine A (2012)
    Chronic kidney disease: Do patients with CKD benefit from lipid-lowering therapy?
    Nat Rev Nephrol, 8 (12), 684-5
    DOI 10.1038/nrneph.2012.240, PubMed 23090449
  11. Holdaas H, Midtvedt K, Åsberg A (2012)
    A drug safety evaluation of everolimus in kidney transplantation
    Expert Opin Drug Saf, 11 (6), 1013-22
    DOI 10.1517/14740338.2012.722993, PubMed 22954349
  12. Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H (2012)
    Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients
    Clin J Am Soc Nephrol, 8 (2), 241-7
    DOI 10.2215/CJN.03760412, PubMed 23160259
  13. Kolset SO, Reinholt FP, Jenssen T (2012)
    Diabetic nephropathy and extracellular matrix
    J Histochem Cytochem, 60 (12), 976-86
    DOI 10.1369/0022155412465073, PubMed 23103723
  14. Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K (2012)
    Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial
    Transplantation, 94 (5), 492-8
    DOI 10.1097/TP.0b013e31825c1d6c, PubMed 22858806
  15. Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
    Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
    Transplant Res, 1 (1), 9
    DOI 10.1186/2047-1440-1-9, PubMed 23369437
  16. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO (2012)
    Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population
    J Hypertens, 30 (3), 497-504
    DOI 10.1097/HJH.0b013e32834f973a, PubMed 22278141
  17. Melsom T, Mathisen UD, Eilertsen BA, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO (2012)
    Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6)
    Clin J Am Soc Nephrol, 7 (11), 1801-10
    DOI 10.2215/CJN.02980312, PubMed 22917703
  18. Mjörnstedt L, Sørensen SS, von Zur Mühlen B, Jespersen B, Hansen JM, Bistrup C, Andersson H, Gustafsson B, Undset LH, Fagertun H, Solbu D, Holdaas H (2012)
    Improved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantation
    Am J Transplant, 12 (10), 2744-53
    DOI 10.1111/j.1600-6143.2012.04162.x, PubMed 22812414
  19. Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012)
    Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome
    Transplantation, 94 (10), 1060-5
    DOI 10.1097/TP.0b013e31826c39de, PubMed 23104251
  20. Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
    A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
    Am J Transplant, 12 (12), 3316-25
    DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930
  21. Soveri I, Abedini S, Holdaas H, Jardine A, Eriksson N, Fellström B (2012)
    Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial
    J Nephrol, 25 (2), 245-54
    DOI 10.5301/JN.2011.8450, PubMed 21725919
  22. Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellström B (2012)
    A cardiovascular risk calculator for renal transplant recipients
    Transplantation, 94 (1), 57-62
    DOI 10.1097/TP.0b013e3182516cdc, PubMed 22683851
  23. Svensson M, Jardine A, Fellström B, Holdaas H (2012)
    Prevention of cardiovascular disease after renal transplantation
    Curr Opin Organ Transplant, 17 (4), 393-400
    DOI 10.1097/MOT.0b013e3283560a3b, PubMed 22790074
  24. Syversveen T, Midtvedt K, Berstad AE, Brabrand K, Strøm EH, Abildgaard A (2012)
    Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients
    Eur Radiol, 22 (10), 2130-7
    DOI 10.1007/s00330-012-2476-4, PubMed 22610533
  25. Valderhaug TG, Bergrem HA, Jenssen T, Hjelmesæth J (2012)
    Comment on: Chakkera et al. Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care 2011;34:2141-2145
    Diabetes Care, 35 (3), e26; author reply e27
    DOI 10.2337/dc11-2046, PubMed 22355029
  26. Valderhaug TG, Hjelmesæth J, Jenssen T, Røislien J, Leivestad T, Hartmann A (2012)
    Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses
    Transplantation, 94 (7), 714-20
    DOI 10.1097/TP.0b013e31825f4434, PubMed 22965263
  27. Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Reisæter AV, Skjærven R (2012)
    Familial factors in the association between preeclampsia and later ESRD
    Clin J Am Soc Nephrol, 7 (11), 1819-26
    DOI 10.2215/CJN.01820212, PubMed 22956264

Publications 2011

  1. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V et al. (2011)
    The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
    Lancet, 377 (9784), 2181-92
    DOI 10.1016/S0140-6736(11)60739-3, PubMed 21663949
  2. Berdal M, Appelbom HI, Eikrem JH, Lund A, Busund LT, Hanes R, Seljelid R, Jenssen T (2011)
    Aminated β-1,3-D-glucan has a dose-dependent effect on wound healing in diabetic db/db mice
    Wound Repair Regen, 19 (5), 579-87
    DOI 10.1111/j.1524-475X.2011.00715.x, PubMed 22092796
  3. Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM (2011)
    Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients
    Clin Transplant, 25 (3), E356-65
    DOI 10.1111/j.1399-0012.2011.01424.x, PubMed 21651619
  4. Brabrand K, Holdaas H, Gunther A, Midtvedt K (2011)
    Spontaneous regression of initially elevated peak systolic velocity in renal transplant artery
    Transpl Int, 24 (6), 555-9
    DOI 10.1111/j.1432-2277.2011.01233.x, PubMed 21332581
  5. Campistol JM, de Fijter JW, Nashan B, Holdaas H, Vítko S, Legendre C (2011)
    Everolimus and long-term outcomes in renal transplantation
    Transplantation, 92 (3 Suppl), S3-26
    DOI 10.1097/TP.0b013e3182230900, PubMed 21799392
  6. Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ (2011)
    Cardiovascular and noncardiovascular mortality among men and women starting dialysis
    Clin J Am Soc Nephrol, 6 (7), 1722-30
    DOI 10.2215/CJN.11331210, PubMed 21734088
  7. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
    Inflammation-associated graft loss in renal transplant recipients
    Nephrol Dial Transplant, 26 (11), 3756-61
    DOI 10.1093/ndt/gfr163, PubMed 21511816
  8. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I (2011)
    The role of cystatin C in improving GFR estimation in the general population
    Am J Kidney Dis, 59 (1), 32-40
    DOI 10.1053/j.ajkd.2011.09.001, PubMed 22001180
  9. Eriksen BO, Melsom T, Mathisen UD, Jenssen TG, Solbu MD, Toft I (2011)
    GFR normalized to total body water allows comparisons across genders and body sizes
    J Am Soc Nephrol, 22 (8), 1517-25
    DOI 10.1681/ASN.2010121321, PubMed 21784894
  10. Hadler-Olsen E, Winberg JO, Reinholt FP, Larsen T, Uhlin-Hansen L, Jenssen T, Berg E, Kolset SO (2011)
    Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy
    ISRN Endocrinol, 2011, 832642
    DOI 10.5402/2011/832642, PubMed 22363890
  11. Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K (2011)
    Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium
    Nephrol Dial Transplant, 26 (8), 2706-11
    DOI 10.1093/ndt/gfq786, PubMed 21285131
  12. Heldal K, Hartmann A, Leivestad T, Lien B, Foss AE, Midtvedt K (2011)
    Renal transplantation is also an option for patients over 70
    Tidsskr Nor Laegeforen, 131 (20), 2004-7
    DOI 10.4045/tidsskr.10.1391, PubMed 22016126
  13. Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
    Rosuvastatin in diabetic hemodialysis patients
    J Am Soc Nephrol, 22 (7), 1335-41
    DOI 10.1681/ASN.2010090987, PubMed 21566054
  14. Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators (2011)
    Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study
    Transplantation, 92 (4), 410-8
    DOI 10.1097/TP.0b013e318224c12d, PubMed 21697773
  15. Holme I, Fellström BC, Jardin AG, Schmieder RE, Zannad F, Holdaas H (2011)
    Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study
    J Intern Med, 271 (5), 463-71
    DOI 10.1111/j.1365-2796.2011.02435.x, PubMed 21812843
  16. Jardine AG, Gaston RS, Fellstrom BC, Holdaas H (2011)
    Prevention of cardiovascular disease in adult recipients of kidney transplants
    Lancet, 378 (9800), 1419-27
    DOI 10.1016/S0140-6736(11)61334-2, PubMed 22000138
  17. Jenssen T, Hartmann A (2011)
    Prevention and management of transplant-associated diabetes
    Expert Opin Pharmacother, 12 (17), 2641-55
    DOI 10.1517/14656566.2011.628936, PubMed 22047007
  18. Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A (2011)
    The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response
    Transplantation, 91 (2), 231-6
    DOI 10.1097/TP.0b013e3181ff8719, PubMed 21048530
  19. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO (2011)
    Estimated GFR associates with cardiovascular risk factors independently of measured GFR
    J Am Soc Nephrol, 22 (5), 927-37
    DOI 10.1681/ASN.2010050479, PubMed 21454717
  20. Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO (2011)
    Impaired fasting glucose is associated with renal hyperfiltration in the general population
    Diabetes Care, 34 (7), 1546-51
    DOI 10.2337/dc11-0235, PubMed 21593291
  21. Meyer K, Bjørk IT, Eide H (2011)
    Intensive care nurses' perceptions of their professional competence in the organ donor process: a national survey
    J Adv Nurs, 68 (1), 104-15
    DOI 10.1111/j.1365-2648.2011.05721.x, PubMed 21645048
  22. Midtvedt K, Holdaas H (2011)
    Belatacept: BENEFIT to the kidney?
    Am J Transplant, 11 (3), 633; author reply 634
    DOI 10.1111/j.1600-6143.2010.03411.x, PubMed 21342454
  23. Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Åsberg A (2011)
    No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
    Nephrol Dial Transplant, 26 (11), 3767-72
    DOI 10.1093/ndt/gfr153, PubMed 21471328
  24. Midtvedt K, Namtvedt T, Scott H, Abedini S, Rocke JC, Dørje C, Foss S, Christen U, Hagness M, Hartmann A (2011)
    Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year
    Transplant Proc, 43 (5), 2107-9
    DOI 10.1016/j.transproceed.2011.01.192, PubMed 21693337
  25. Mjøen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
    Age, gender, and body mass index are associated with renal function after kidney donation
    Clin Transplant, 25 (6), E579-83
    DOI 10.1111/j.1399-0012.2011.01503.x, PubMed 21906171
  26. Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 27 (1), 443-7
    DOI 10.1093/ndt/gfr303, PubMed 21636826
  27. Mjøen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
    Quality of life in kidney donors
    Am J Transplant, 11 (6), 1315-9
    DOI 10.1111/j.1600-6143.2011.03517.x, PubMed 21486387
  28. Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
    Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
    Transplantation, 92 (2), 217-23
    DOI 10.1097/TP.0b013e31821fad25, PubMed 21685829
  29. März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C, German Diabetes and Dialysis Study Investigators (2011)
    Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
    Clin J Am Soc Nephrol, 6 (6), 1316-25
    DOI 10.2215/CJN.09121010, PubMed 21493741
  30. Norby GE, Günther A, Mjøen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
    Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
    Rheumatology (Oxford), 50 (9), 1659-64
    DOI 10.1093/rheumatology/ker186, PubMed 21624893
  31. Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
    Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
    Arthritis Rheum, 63 (3), 733-7
    DOI 10.1002/art.30184, PubMed 21360503
  32. Reine TM, Kusche-Gullberg M, Feta A, Jenssen T, Kolset SO (2011)
    Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells
    Glycoconj J, 29 (1), 67-76
    DOI 10.1007/s10719-011-9365-y, PubMed 22187328
  33. Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
    The kidney transplantation program in Norway since 2000
    Clin Transpl, 111-8
    PubMed 22755407
  34. Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
    A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8)
    Blood Purif, 32 (3), 151-5
    DOI 10.1159/000325227, PubMed 21659742
  35. Svensson M, Dahle DO, Mjøen G, Weihrauch G, Scharnagl H, Dobnig H, März W, Jardine A, Fellström B, Holdaas H (2011)
    Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study
    Nephrol Dial Transplant, 27 (6), 2571-5
    DOI 10.1093/ndt/gfr694, PubMed 22172725
  36. Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Berstad AE (2011)
    Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement
    Acta Radiol, 52 (8), 920-6
    DOI 10.1258/ar.2011.110215, PubMed 21873503
  37. Syversveen T, Midtvedt K, Brabrand K, Øyen O, Foss A, Scholz T (2011)
    Prophylactic peritoneal fenestration to prevent morbidity after kidney transplantation: a randomized study
    Transplantation, 92 (2), 196-202
    DOI 10.1097/TP.0b013e318220f57b, PubMed 21597401
  38. Tangeraas T, Midtvedt K, Cvancarova M, Hirth A, Fredriksen PM, Tonstad S, Isaksen GA, Bjerre A (2011)
    Cardiorespiratory fitness in young adults with a history of renal transplantation in childhood
    Pediatr Nephrol, 26 (11), 2041-9
    DOI 10.1007/s00467-011-1898-6, PubMed 21541798
  39. Valderhaug TG, Hjelmesæth J, Hartmann A, Røislien J, Bergrem HA, Leivestad T, Line PD, Jenssen T (2011)
    The association of early post-transplant glucose levels with long-term mortality
    Diabetologia, 54 (6), 1341-9
    DOI 10.1007/s00125-011-2105-9, PubMed 21409415
  40. Vethe NT, Midtvedt K, Asberg A, Amundsen R, Bergan S (2011)
    [Drug interactions and immunosuppression in organ transplant recipients]
    Tidsskr Nor Laegeforen, 131 (20), 2000-3
    DOI 10.4045/tidsskr.11.0138, PubMed 22016125
  41. Øfjord ES, Skag A, Helberg S, Aarskog D, Risberg K, Jacobsen T, Nasrala S, Bakken S, Syversen U, Jenssen T (2011)
    Medicinal prevention of pre-diabetes--no purpose?
    Tidsskr Nor Laegeforen, 131 (15), 1418-9
    DOI 10.4045/tidsskr.10.1459, PubMed 21844941

Publications 2010

  1. Abedini S, Meinitzer A, Holme I, März W, Weihrauch G, Fellstrøm B, Jardine A, Holdaas H (2010)
    Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients
    Kidney Int, 77 (1), 44-50
    DOI 10.1038/ki.2009.382, PubMed 19847152
  2. Asberg A, Falck P, Undset LH, Dørje C, Holdaas H, Hartmann A, Midtvedt K (2010)
    Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study
    Ther Drug Monit, 32 (2), 152-8
    DOI 10.1097/FTD.0b013e3181d3f822, PubMed 20216113
  3. Asberg A, Rollag H, Hartmann A (2010)
    Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients
    Expert Opin Pharmacother, 11 (7), 1159-66
    DOI 10.1517/14656561003742954, PubMed 20367273
  4. Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010)
    Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy
    Clin J Am Soc Nephrol, 5 (4), 616-22
    DOI 10.2215/CJN.07501009, PubMed 20133490
  5. Bryhni B, Arnesen E, Jenssen TG (2010)
    Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study
    BMC Endocr Disord, 10, 21
    DOI 10.1186/1472-6823-10-21, PubMed 21162746
  6. Dolgos S, Hartmann A, Isaksen GA, Simonsen S, Bjørtuft Ø, Boberg KM, Bollerslev J (2010)
    Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study
    Clin Transplant, 24 (5), E145-52
    DOI 10.1111/j.1399-0012.2010.01231.x, PubMed 20236290
  7. Elgstoen KB, Johnsen LF, Woldseth B, Morkrid L, Hartmann A (2010)
    Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria
    Nephrol Dial Transplant, 25 (7), 2341-5
    DOI 10.1093/ndt/gfq065, PubMed 20167571
  8. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I (2010)
    Cystatin C is not a better estimator of GFR than plasma creatinine in the general population
    Kidney Int, 78 (12), 1305-11
    DOI 10.1038/ki.2010.321, PubMed 20844470
  9. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R (2010)
    Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up
    Diabet Med, 27 (10), 1107-15
    DOI 10.1111/j.1464-5491.2010.03092.x, PubMed 20854377
  10. Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S (2010)
    Acute renal failure early after heart transplantation: risk factors and clinical consequences
    Clin Transplant, 24 (6), E207-13
    DOI 10.1111/j.1399-0012.2010.01225.x, PubMed 20184627
  11. Gude E, Gullestad L, Arora S, Simonsen S, Hoel I, Hartmann A, Holdaas H, Fiane AE, Geiran OR, Andreassen AK (2010)
    Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation
    J Heart Lung Transplant, 29 (6), 641-7
    DOI 10.1016/j.healun.2010.01.005, PubMed 20304681
  12. Guest JF, Jenssen T, Houge G, Aaseboe W, Tøndel C, Svarstad E (2010)
    Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion
    Eur J Clin Invest, 40 (12), 1104-12
    DOI 10.1111/j.1365-2362.2010.02363.x, PubMed 21070219
  13. Hirsch HH, Hartmann A (2010)
    Immunotherapy for invasive fungal infections in transplant patients: back to the future?
    Am J Transplant, 10 (8), 1719-20
    DOI 10.1111/j.1600-6143.2010.03189.x, PubMed 20636453
  14. Hjelmesæth J, Røislien J, Nordstrand N, Hofsø D, Hager H, Hartmann A (2010)
    Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
    BMC Endocr Disord, 10, 6
    DOI 10.1186/1472-6823-10-6, PubMed 20398422
  15. Hofsø D, Jenssen T, Bollerslev J, Ueland T, Godang K, Stumvoll M, Sandbu R, Røislien J, Hjelmesæth J (2010)
    Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
    Eur J Endocrinol, 164 (2), 231-8
    DOI 10.1530/EJE-10-0804, PubMed 21078684
  16. Hofsø D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollerslev J, Godang K, Sandbu R, Røislien J, Hjelmesaeth J (2010)
    Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
    Eur J Endocrinol, 163 (5), 735-45
    DOI 10.1530/EJE-10-0514, PubMed 20798226
  17. McQuarrie EP, Fellström BC, Holdaas H, Jardine AG (2010)
    Cardiovascular disease in renal transplant recipients
    J Ren Care, 36 Suppl 1, 136-45
    DOI 10.1111/j.1755-6686.2010.00160.x, PubMed 20586909
  18. Meen AJ, Øynebråten I, Reine TM, Duelli A, Svennevig K, Pejler G, Jenssen T, Kolset SO (2010)
    Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1
    J Biol Chem, 286 (4), 2636-47
    DOI 10.1074/jbc.M110.151944, PubMed 21075844
  19. Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
    One- and five-year follow-ups on blood pressure and renal function in kidney donors
    Transpl Int, 24 (1), 73-7
    DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180
  20. Mjøen G, Holdaas H, Pfeffer P, Line PD, Øyen O (2010)
    Minimally invasive living donor nephrectomy - introduction of hand-assistance
    Transpl Int, 23 (10), 1008-14
    DOI 10.1111/j.1432-2277.2010.01087.x, PubMed 20412538
  21. Myhre HA, Øyen O, Kårbø Ø, Midtvedt K (2010)
    Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report
    NDT Plus, 3 (1), 100-2
    DOI 10.1093/ndtplus/sfp148, PubMed 25949418
  22. NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E et al. (2010)
    Effect of nateglinide on the incidence of diabetes and cardiovascular events
    N Engl J Med, 362 (16), 1463-76
    DOI 10.1056/NEJMoa1001122, PubMed 20228402
  23. NAVIGATOR Study Group, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E et al. (2010)
    Effect of valsartan on the incidence of diabetes and cardiovascular events
    N Engl J Med, 362 (16), 1477-90
    DOI 10.1056/NEJMoa1001121, PubMed 20228403
  24. Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
    [Lupus-nephritis--diagnosis and treatment]
    Tidsskr Nor Laegeforen, 130 (11), 1140-4
    DOI 10.4045/tidsskr.09.0583, PubMed 20531500
  25. Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
    Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
    Ann Rheum Dis, 69 (8), 1484-7
    DOI 10.1136/ard.2009.122796, PubMed 20498208
  26. Skottheim IB, Jakobsen GS, Stormark K, Christensen H, Hjelmesaeth J, Jenssen T, Asberg A, Sandbu R (2010)
    Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch
    Clin Pharmacol Ther, 87 (6), 699-705
    DOI 10.1038/clpt.2010.32, PubMed 20445535
  27. Solli O, Jenssen T, Kristiansen IS (2010)
    Diabetes: cost of illness in Norway
    BMC Endocr Disord, 10, 15
    DOI 10.1186/1472-6823-10-15, PubMed 20854689
  28. Strøm EH, Reinholt FP, Midtvedt K (2010)
    JC virus-associated nephropathy: lack of convincing documentation of the diagnosis
    Transpl Infect Dis, 13 (1), 93-4
    DOI 10.1111/j.1399-3062.2010.00594.x, PubMed 21299773
  29. Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Jakobsen JA, Berstad AE (2010)
    Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study
    Transpl Int, 24 (1), 100-5
    DOI 10.1111/j.1432-2277.2010.01165.x, PubMed 20819192
  30. Tangeraas T, Midtvedt K, Fredriksen PM, Cvancarova M, Mørkrid L, Bjerre A (2010)
    Cardiorespiratory fitness is a marker of cardiovascular health in renal transplanted children
    Pediatr Nephrol, 25 (11), 2343-50
    DOI 10.1007/s00467-010-1596-9, PubMed 20676694
  31. Aasebø W, Strøm EH, Hovig T, Undset LH, Heiberg A, Jenssen T (2010)
    Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation
    NDT Plus, 3 (3), 303-305
    DOI 10.1093/ndtplus/sfq036, PubMed 28657066

Publications 2009

  1. Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
    Cerebrovascular events in renal transplant recipients
    Transplantation, 87 (1), 112-7
    DOI 10.1097/TP.0b013e31818bfce8, PubMed 19136900
  2. Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H, ALERT study group (2009)
    Inflammation in renal transplantation
    Clin J Am Soc Nephrol, 4 (7), 1246-54
    DOI 10.2215/CJN.00930209, PubMed 19541816
  3. Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
    Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients
    Transplantation, 87 (8), 1221-4
    DOI 10.1097/TP.0b013e31819f1001, PubMed 19384170
  4. Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
    Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
    Clin Transplant, 23 (4), 511-8
    DOI 10.1111/j.1399-0012.2009.00962.x, PubMed 19210527
  5. Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, Jenssen T (2009)
    Glucose tolerance before and after renal transplantation
    Nephrol Dial Transplant, 25 (3), 985-92
    DOI 10.1093/ndt/gfp566, PubMed 19854851
  6. Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A (2009)
    Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
    Antivir Ther, 14 (5), 697-704
    PubMed 19704173
  7. Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S (2009)
    Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study
    J Transl Med, 7, 64
    DOI 10.1186/1479-5876-7-64, PubMed 19635156
  8. Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J (2009)
    Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation
    Scand J Clin Lab Invest, 69 (2), 161-7
    DOI 10.1080/00365510802449634, PubMed 18972258
  9. Dolgos S, Hartmann A, Jenssen T, Isaksen GA, Pfeffer P, Bollerslev J (2009)
    Determinants of short-term changes in body composition following renal transplantation
    Scand J Urol Nephrol, 43 (1), 76-83
    DOI 10.1080/00365590802273226, PubMed 18777442
  10. Falck P, Midtvedt K, Vân Lê TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
    A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
    Clin Pharmacokinet, 48 (9), 615-23
    DOI 10.2165/11313380-000000000-00000, PubMed 19725595
  11. Fellstrom B, Jardine A, Holdaas H, AURORA Executive Steering Comm (2009)
    Rosuvastatin in Patients Undergoing Hemodialysis REPLY
    N. Engl. J. Med., 361 (1), 94-95
  12. Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F, AURORA Study Group (2009)
    Cardiovascular disease in patients with renal disease: the role of statins
    Curr Med Res Opin, 25 (1), 271-85
    DOI 10.1185/03007990802622064, PubMed 19210158
  13. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP et al. (2009)
    Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    N Engl J Med, 360 (14), 1395-407
    DOI 10.1056/NEJMoa0810177, PubMed 19332456
  14. Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jørgensen PF, Scholz T, Midtvedt K (2009)
    Kidneys from deceased donors more than 75 years perform acceptably after transplantation
    Transplantation, 87 (10), 1437-41
    DOI 10.1097/TP.0b013e3181a4ebd2, PubMed 19461478
  15. Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K (2009)
    Benefit of kidney transplantation beyond 70 years of age
    Nephrol Dial Transplant, 25 (5), 1680-7
    DOI 10.1093/ndt/gfp681, PubMed 20038521
  16. Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
    Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity
    Transplantation, 87 (7), 1045-51
    DOI 10.1097/TP.0b013e31819cdddd, PubMed 19352126
  17. Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, Røislien J, Bollerslev J (2009)
    Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study
    Cardiovasc Diabetol, 8, 7
    DOI 10.1186/1475-2840-8-7, PubMed 19187564
  18. Hofsø D, Jenssen T, Bollerslev J, Røislien J, Hager H, Hjelmesaeth J (2009)
    Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study
    Diabetes Res Clin Pract, 86 (1), e9-11
    DOI 10.1016/j.diabres.2009.06.016, PubMed 19608292
  19. Hofsø D, Jenssen T, Hager H, Røislien J, Hjelmesaeth J (2009)
    Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects
    Obes Surg, 20 (3), 302-7
    DOI 10.1007/s11695-009-0022-5, PubMed 19949889
  20. Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J (2009)
    Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
    Eur J Endocrinol, 161 (3), 451-8
    DOI 10.1530/EJE-09-0421, PubMed 19542241
  21. Holme I, Fayyad R, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Holdaas H, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
    Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
    J Intern Med, 267 (6), 567-75
    DOI 10.1111/j.1365-2796.2009.02176.x, PubMed 20141566
  22. Holme I, Fellstrom B, Jardine A, Holdaas H (2009)
    Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients
    Atherosclerosis, 208 (1), 234-9
    DOI 10.1016/j.atherosclerosis.2009.06.020, PubMed 19596331
  23. Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A (2009)
    Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease
    Clin Infect Dis, 49 (8), 1160-6
    DOI 10.1086/605633, PubMed 19751151
  24. Midtvedt K, Bitter J, Dørje C, Bjørneklett R, Holdaas H (2009)
    Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation
    Transplantation, 87 (12), 1901-3
    DOI 10.1097/TP.0b013e3181a991ca, PubMed 19543075
  25. Midtvedt K, Midtvedt T (2009)
    [Childhood diarrhea research in developing countries]
    Tidsskr Nor Laegeforen, 129 (15), 1484-5
    DOI 10.4045/tidsskr.09.0715, PubMed 19690601
  26. Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
    Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
    Transplantation, 88 (11), 1273-9
    DOI 10.1097/TP.0b013e3181bb44fd, PubMed 19996926
  27. Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group (2009)
    Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study
    Arthritis Rheum, 60 (4), 1060-4
    DOI 10.1002/art.24379, PubMed 19333947
  28. Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM, JEWEL Study Group (2009)
    International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme
    Eur J Cardiovasc Prev Rehabil, 16 (4), 472-80
    DOI 10.1097/HJR.0b013e32832b63f5, PubMed 19407658
  29. Skottheim IB, Stormark K, Christensen H, Jakobsen GS, Hjelmesaeth J, Jenssen T, Reubsaet JL, Sandbu R, Asberg A (2009)
    Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients
    Clin Pharmacol Ther, 86 (3), 311-8
    DOI 10.1038/clpt.2009.82, PubMed 19494810
  30. Solbu MD, Jenssen TG, Eriksen BO, Toft I (2009)
    Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study
    Metabolism, 58 (3), 408-15
    DOI 10.1016/j.metabol.2008.10.016, PubMed 19217459
  31. Soveri I, Abedini S, Holdaas H, Jardine A, Eriksson N, Fellström B (2009)
    Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment
    Clin Transplant, 23 (6), 914-20
    DOI 10.1111/j.1399-0012.2009.01025.x, PubMed 19594771
  32. Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
    Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
    Transplantation, 88 (3), 429-34
    DOI 10.1097/TP.0b013e3181af1f53, PubMed 19667949
  33. Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
    Experience from an active preemptive kidney transplantation program--809 cases revisited
    Transplantation, 88 (5), 672-7
    DOI 10.1097/TP.0b013e3181b27b7e, PubMed 19741464
  34. Aasebø W (2009)
    ECG-voltage in alcoholics and non-alcoholics with acute alcohol intoxication
    J Forensic Leg Med, 16 (7), 381-4
    DOI 10.1016/j.jflm.2009.01.016, PubMed 19733325
  35. Aasebø W, Hartmann A, Jenssen T (2009)
    Predictors of anemia in patients on hemodialysis
    Hemodial Int, 13 (3), 335-9
    DOI 10.1111/j.1542-4758.2009.00376.x, PubMed 19614760
  36. Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
    Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
    Nephrol Dial Transplant, 25 (4), 1289-93
    DOI 10.1093/ndt/gfp617, PubMed 19934089

Publications 2008

  1. Apeland T, Hartmann A (2008)
    Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation
    Nephrol Dial Transplant, 23 (6), 2091-4
    DOI 10.1093/ndt/gfn099, PubMed 18319357
  2. Bergrem HA, Bergrem H, Hartmann A, Hjelmesaeth J, Jenssen T (2008)
    Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation
    Ther Drug Monit, 30 (5), 583-90
    DOI 10.1097/FTD.0b013e318187bb2f, PubMed 18728625
  3. Bremer S, Mandla R, Vethe NT, Rasmussen I, Rootwelt H, Line PD, Midtvedt K, Bergan S (2008)
    Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression
    Transplantation, 85 (1), 55-61
    DOI 10.1097/01.tp.0000296854.68123.03, PubMed 18192912
  4. Dolgos S, Hartmann A, Bønsnes S, Ueland T, Isaksen GA, Godang K, Pfeffer P, Bollerslev J (2008)
    Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
    Clin Transplant, 22 (4), 462-8
    DOI 10.1111/j.1399-0012.2008.00810.x, PubMed 18318737
  5. Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group (2008)
    The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study
    Clin Ther, 30 (3), 482-98
    DOI 10.1016/j.clinthera.2008.03.006, PubMed 18405787
  6. Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K (2008)
    Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients
    Transplantation, 86 (10), 1379-83
    DOI 10.1097/TP.0b013e31818aa4b6, PubMed 19034006
  7. Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K (2008)
    Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
    Transplantation, 85 (2), 179-84
    DOI 10.1097/TP.0b013e31815feede, PubMed 18212621
  8. Foss A, Gunther A, Line PD, Brabrand K, Holdaas H, Hartmann A, Midtvedt K (2008)
    Long-term clinical outcome of paediatric kidneys transplanted to adults
    Nephrol Dial Transplant, 23 (2), 726-9
    DOI 10.1093/ndt/gfm826, PubMed 18198285
  9. Gunther A, Foss A, Holdaas H, Brabrand K, Hartmann A, Line PD, Midtvedt K (2008)
    Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients
    Nephrol Dial Transplant, 23 (12), 4041-3
    DOI 10.1093/ndt/gfn358, PubMed 18586763
  10. Hesselink DA, van Schaik RH, van Agteren M, de Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Pisarski P, Le Meur Y, Mamelok RD, van Gelder T (2008)
    CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
    Pharmacogenet Genomics, 18 (4), 339-48
    DOI 10.1097/FPC.0b013e3282f75f88, PubMed 18334918
  11. Holdaas H (2008)
    Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
    Eur Heart J, 29 (4), 425-6
    DOI 10.1093/eurheartj/ehm628, PubMed 18276612
  12. Holdaas H, Bentdal O, Pfeffer P, Mjørnstedt L, Solbu D, Midtvedt K (2008)
    Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study
    Clin Transplant, 22 (3), 366-71
    DOI 10.1111/j.1399-0012.2008.00795.x, PubMed 18279419
  13. Jørgensen L, Heuch I, Jenssen T, Jacobsen BK (2008)
    Association of albuminuria and cancer incidence
    J Am Soc Nephrol, 19 (5), 992-8
    DOI 10.1681/ASN.2007060712, PubMed 18256361
  14. Jørgensen L, Jenssen T, Heuch I, Jacobsen BK (2008)
    The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic persons
    J Intern Med, 264 (5), 493-501
    DOI 10.1111/j.1365-2796.2008.01992.x, PubMed 18624904
  15. Kronborg J, Solbu M, Njølstad I, Toft I, Eriksen BO, Jenssen T (2008)
    Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study
    Nephrol Dial Transplant, 23 (9), 2818-26
    DOI 10.1093/ndt/gfn148, PubMed 18400822
  16. Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann A (2008)
    Pregnancy and birth after kidney donation: the Norwegian experience
    Am J Transplant, 9 (4), 820-4
    DOI 10.1111/j.1600-6143.2008.02427.x, PubMed 18853953
  17. Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
    Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
    Nephrol Dial Transplant, 23 (12), 4054-60
    DOI 10.1093/ndt/gfn355, PubMed 18577532
  18. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I (2008)
    Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study
    Atherosclerosis, 201 (2), 398-406
    DOI 10.1016/j.atherosclerosis.2008.02.027, PubMed 18405901
  19. Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I (2008)
    Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
    Atherosclerosis, 204 (2), 503-8
    DOI 10.1016/j.atherosclerosis.2008.11.002, PubMed 19091314
  20. Tangeraas T, Bjerre A, Lien B, Kyte A, Monn E, Cvancarova M, Leivestad T, Reisaeter AV (2008)
    Long-term outcome of pediatric renal transplantation: the Norwegian experience in three eras 1970-2006
    Pediatr Transplant, 12 (7), 762-8
    DOI 10.1111/j.1399-3046.2007.00896.x, PubMed 18208441
  21. van Agteren M, Armstrong VW, van Schaik RH, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M, van Gelder T (2008)
    AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism
    Ther Drug Monit, 30 (4), 439-44
    DOI 10.1097/FTD.0b013e318180c709, PubMed 18641546
  22. van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, Mamelok RD (2008)
    Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial
    Transplantation, 86 (8), 1043-51
    DOI 10.1097/TP.0b013e318186f98a, PubMed 18946341
  23. Witczak BJ, Hartmann A, Geiran OR, Bugge JF (2008)
    Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine
    Eur J Anaesthesiol, 25 (4), 319-25
    DOI 10.1017/S0265021507003158, PubMed 18182121
  24. Zwisler AD, Soja AM, Rasmussen S, Frederiksen M, Abedini S, Appel J, Rasmussen H, Gluud C, Iversen L, Sigurd B, Madsen M, Fischer-Hansen J, DANREHAB Group (2008)
    Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial
    Am Heart J, 155 (6), 1106-13
    DOI 10.1016/j.ahj.2007.12.033, PubMed 18513526
  25. Aasebø W, Homb-Vesteraas NA, Hartmann A, Stavem K (2008)
    Life situation and quality of life in young adult kidney transplant recipients
    Nephrol Dial Transplant, 24 (1), 304-8
    DOI 10.1093/ndt/gfn537, PubMed 18840897

Publications 2007

  1. Berdal M, Appelbom HI, Eikrem JH, Lund A, Zykova S, Busund LT, Seljelid R, Jenssen T (2007)
    Aminated beta-1,3-D-glucan improves wound healing in diabetic db/db mice
    Wound Repair Regen, 15 (6), 825-32
    DOI 10.1111/j.1524-475X.2007.00286.x, PubMed 18028130
  2. Ekberg H, Kyllönen L, Madsen S, Grave G, Solbu D, Holdaas H (2007)
    Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists
    Transplantation, 84 (8), 1052-4
    DOI 10.1097/01.tp.0000284983.89207.1a, PubMed 17989612
  3. Ekberg H, Kyllönen L, Madsen S, Grave G, Solbu D, Holdaas H (2007)
    Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients
    Transplantation, 83 (3), 282-9
    DOI 10.1097/01.tp.0000251923.14697.f5, PubMed 17297402
  4. Falck P, Guldseth H, Asberg A, Midtvedt K, Reubsaet JL (2007)
    Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry
    J Chromatogr B Analyt Technol Biomed Life Sci, 852 (1-2), 345-52
    DOI 10.1016/j.jchromb.2007.01.039, PubMed 17301005
  5. Falck P, Vethe NT, Asberg A, Midtvedt K, Bergan S, Reubsaet JL, Holdaas H (2007)
    Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
    Nephrol Dial Transplant, 23 (3), 1048-53
    DOI 10.1093/ndt/gfm632, PubMed 17956893
  6. Fellström B, Holdaas H, Jardine AG, Rose H, Schmieder R, Wilpshaar W, Zannad F, AURORA Study Group (2007)
    Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study
    Kidney Blood Press Res, 30 (5), 314-22
    DOI 10.1159/000106803, PubMed 17671394
  7. Foss A, Line PD, Brabrand K, Midtvedt K, Hartmann A (2007)
    A prospective study on size and function of paediatric kidneys (<10 years) transplanted to adults
    Nephrol Dial Transplant, 22 (6), 1738-42
    DOI 10.1093/ndt/gfm080, PubMed 17384415
  8. Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K (2007)
    Kidney transplantation in the elderly--the Norwegian experience
    Nephrol Dial Transplant, 23 (3), 1026-31
    DOI 10.1093/ndt/gfm719, PubMed 18079146
  9. Hjelmesaeth J (2007)
    [Increased risk of myocardial infarction following rosiglitazone?]
    Tidsskr Nor Laegeforen, 127 (13), 1809
    PubMed 17599146
  10. Hjelmesaeth J (2007)
    [Morbid obesity]
    Tidsskr Nor Laegeforen, 127 (1), 14
    PubMed 17205081
  11. Hjelmesaeth J, Asberg A, Hartmann A, Jenssen T (2007)
    The effect of ciclosporin on insulin secretion and resistance - Reply
    Nephrol. Dial. Transplant., 22 (11), 3359
  12. Hjelmesaeth J, Hagen LT, Asberg A, Midtvedt K, Størset O, Halvorsen CE, Mørkrid L, Hartmann A, Jenssen T (2007)
    The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
    Nephrol Dial Transplant, 22 (6), 1743-9
    DOI 10.1093/ndt/gfl820, PubMed 17299003
  13. Hjelmesaeth J, Jenssen T, Hartmann A (2007)
    Ghrelin, atherosclerosis, and glucose: GAG or causal relationships?
    Transplantation, 84 (10), 1220-1
    DOI 10.1097/01.tp.0000287429.29273.ca, PubMed 18049105
  14. Inan I, Gervaz P, Hagen M, Morel P (2007)
    Multimedia article. Laparoscopic repair of parastomal hernia using a porcine dermal collagen (Permacol) implant
    Dis Colon Rectum, 50 (9), 1465
    DOI 10.1007/s10350-007-0275-9, PubMed 17619220
  15. Jørgensen L, Jenssen T, Ahmed L, Bjørnerem A, Joakimsen R, Jacobsen BK (2007)
    Albuminuria and risk of nonvertebral fractures
    Arch Intern Med, 167 (13), 1379-85
    DOI 10.1001/archinte.167.13.1379, PubMed 17620531
  16. Kronborg J, Jenssen T, Njølstad I, Toft I, Eriksen BO (2007)
    Metabolic risk factors associated with serum creatinine in a non-diabetic population
    Eur J Epidemiol, 22 (10), 707-13
    DOI 10.1007/s10654-007-9164-8, PubMed 17653600
  17. Kronborg J, Johnsen SH, Njølstad I, Toft I, Eriksen BO, Jenssen T (2007)
    Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study
    Diabetologia, 50 (8), 1607-14
    DOI 10.1007/s00125-007-0715-z, PubMed 17558484
  18. Midtvedt K, Bjorang O, Letting AS (2007)
    Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy
    Clin Transplant, 21 (4), 571-3
    DOI 10.1111/j.1399-0012.2007.00673.x, PubMed 17645722
  19. Sagedal S, Rollag H, Hartmann A (2007)
    Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk
    Clin Transplant, 21 (3), 309-13
    DOI 10.1111/j.1399-0012.2006.00639.x, PubMed 17488378
  20. Singer JB, Holdaas H, Jardine AG, Fellstrøm B, Os I, Bermann G, Meyer JM, Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators (2007)
    Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients
    J Lipid Res, 48 (9), 2072-8
    DOI 10.1194/jlr.M700076-JLR200, PubMed 17563401
  21. Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A (2007)
    Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
    Transplantation, 84 (9), 1125-30
    DOI 10.1097/01.tp.0000287191.45032.38, PubMed 17998867
  22. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators (2007)
    Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus
    Am J Transplant, 7 (6), 1506-14
    DOI 10.1111/j.1600-6143.2007.01749.x, PubMed 17359512
  23. Voytovich MH, Haukereid C, Hjelmesaeth J, Hartmann A, Løvik A, Jenssen T (2007)
    Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients
    Clin Transplant, 21 (2), 246-51
    DOI 10.1111/j.1399-0012.2006.00634.x, PubMed 17425753
  24. Witczak BJ, Jenssen T, Endresen K, Røislien J, Hartmann A (2007)
    Risk factors for mortality in diabetic nephropathy patients accepted for transplantation
    Transplantation, 84 (3), 356-61
    DOI 10.1097/01.tp.0000276935.31584.4c, PubMed 17700161
  25. Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007)
    Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes
    Transplantation, 83 (5), 600-6
    DOI 10.1097/01.tp.0000255583.34329.dd, PubMed 17353781

Publications 2006

  1. Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
    Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
    Transplantation, 82 (1), 62-8
    DOI 10.1097/01.tp.0000225803.04995.2b, PubMed 16861943
  2. Aune E, Hjelmesaeth J, Fox KA, Endresen K, Otterstad JE (2006)
    High mortality rates in conservatively managed patients with acute coronary syndrome
    Scand Cardiovasc J, 40 (3), 137-44
    DOI 10.1080/14017430600699889, PubMed 16798660
  3. Boberg KM, Foss A, Midtvedt K, Schrumpf E (2006)
    ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
    Clin Transplant, 20 (2), 265-8
    DOI 10.1111/j.1399-0012.2005.00470.x, PubMed 16640538
  4. Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C (2006)
    Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Clin Transplant, 20 (3), 336-9
    DOI 10.1111/j.1399-0012.2006.00489.x, PubMed 16824151
  5. Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group (2006)
    No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study
    Clin Transplant, 20 (6), 732-9
    DOI 10.1111/j.1399-0012.2006.00555.x, PubMed 17100723
  6. Hartmann A (2006)
    [Hypercalcemia and proteinuria]
    Tidsskr Nor Laegeforen, 126 (20), 2668
    PubMed 17063596
  7. Hartmann A, Holdaas H, Os I, Hunderi OH, Hallan S, Widerøe TE, Svarstad E, Selvig K, Skjønsberg H, Toft I (2006)
    [Staging and measurement of renal function in chronic renal conditions]
    Tidsskr Nor Laegeforen, 126 (9), 1198-200
    PubMed 16670740
  8. Hartmann A, Sagedal S, Hjelmesaeth J (2006)
    The natural course of cytomegalovirus infection and disease in renal transplant recipients
    Transplantation, 82 (2 Suppl), S15-7
    DOI 10.1097/01.tp.0000230460.42558.b0, PubMed 16858268
  9. Hjelmesaeth J, Flyvbjerg A, Jenssen T, Frystyk J, Ueland T, Hagen M, Hartmann A (2006)
    Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy
    Clin J Am Soc Nephrol, 1 (3), 575-82
    DOI 10.2215/CJN.01471005, PubMed 17699261
  10. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T (2006)
    The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events
    Kidney Int, 69 (3), 588-95
    DOI 10.1038/sj.ki.5000116, PubMed 16395250
  11. Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Røislien J, Hartmann A (2006)
    Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
    J Am Soc Nephrol, 17 (6), 1746-54
    DOI 10.1681/ASN.2005121368, PubMed 16687626
  12. Holdaas H, Hagen E, Asberg A, Lund K, Hartman A, Vaidyanathan S, Prasad P, He YL, Yeh CM, Bigler H, Rouilly M, Denouel J (2006)
    Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients
    Int J Clin Pharmacol Ther, 44 (4), 163-71
    DOI 10.5414/cpp44163, PubMed 16625985
  13. Holdaas H, Singh D (2006)
    Fluvastatin may be similarly effective in older and younger people
    Evid Based Cardiovasc Med, 10 (1), 11-2
    DOI 10.1016/j.ebcm.2006.01.001, PubMed 16530657
  14. Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J (2006)
    The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials
    Int J Cardiol, 117 (1), 64-74
    DOI 10.1016/j.ijcard.2006.06.003, PubMed 16889855
  15. Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J (2006)
    The renal safety profile of fluvastatin: results of a pooled analysis
    Ren Fail, 28 (6), 487-92
    DOI 10.1080/08860220600781260, PubMed 16928618
  16. Holdaas H, Westlie L (2006)
    [A renaissance for home hemodialysis?]
    Tidsskr Nor Laegeforen, 126 (21), 2785
    PubMed 17086216
  17. Jenssen T (2006)
    The many faces of proinsulin
    Scand J Clin Lab Invest, 66 (1), 5-6
    DOI 10.1080/00365510500474512, PubMed 16464781
  18. Jørgensen L, Jenssen T, Johnsen SH, Mathiesen EB, Heuch I, Joakimsen O, Fosse E, Jacobsen BK (2006)
    Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study
    Eur Heart J, 28 (3), 363-9
    DOI 10.1093/eurheartj/ehl394, PubMed 17132646
  19. Kaindl AM, Asimiadou S, Manthey D, Hagen MV, Turski L, Ikonomidou C (2006)
    Antiepileptic drugs and the developing brain
    Cell Mol Life Sci, 63 (4), 399-413
    DOI 10.1007/s00018-005-5348-0, PubMed 16389461
  20. Mandla R, Midtvedt K, Line PD, Hartmann A, Bergan S (2006)
    Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients
    Transpl Int, 19 (1), 44-53
    DOI 10.1111/j.1432-2277.2005.00228.x, PubMed 16359376
  21. Midtvedt K, Brabrand K (2006)
    [Hemodynamic renal changes in right-sided heart failure]
    Tidsskr Nor Laegeforen, 126 (10), 1356; author reply 1356
    PubMed 16691279
  22. Oien CM, Reisaeter AV, Os I, Jardine A, Fellström B, Holdaas H (2006)
    Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study
    Clin Transplant, 20 (3), 374-82
    DOI 10.1111/j.1399-0012.2006.00496.x, PubMed 16824157
  23. Olsen GH, Andresen PA, Hilmarsen HT, Bjørang O, Scott H, Midtvedt K, Rinaldo CH (2006)
    Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients
    J Med Virol, 78 (3), 384-93
    DOI 10.1002/jmv.20551, PubMed 16419108
  24. Oyen O, Strøm EH, Midtvedt K, Bentdal O, Hartmann A, Bergan S, Pfeffer P, Brekke IB (2006)
    Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome
    Am J Transplant, 6 (2), 412-8
    DOI 10.1111/j.1600-6143.2005.01184.x, PubMed 16426329
  25. Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B (2006)
    Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality
    Nephrol Dial Transplant, 21 (8), 2282-9
    DOI 10.1093/ndt/gfl095, PubMed 16574686
  26. Vethe NT, Mandla R, Line PD, Midtvedt K, Hartmann A, Bergan S (2006)
    Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment
    Scand J Clin Lab Invest, 66 (1), 31-44
    DOI 10.1080/00365510500420259, PubMed 16464785
  27. Voytovich MH, Asberg A, Hjelmesaeth J, Jenssen T, Hartmann A (2006)
    Association between insulin resistance and endothelial dysfunction in renal transplant recipients
    Clin Transplant, 20 (2), 195-9
    DOI 10.1111/j.1399-0012.2005.00465.x, PubMed 16640526
  28. Witczak BJ, Hartmann A, Jenssen T, Foss A, Endresen K (2006)
    Routine coronary angiography in diabetic nephropathy patients before transplantation
    Am J Transplant, 6 (10), 2403-8
    DOI 10.1111/j.1600-6143.2006.01491.x, PubMed 16952302

Publications 2005

  1. Bryhni B, Jenssen TG, Olafsen K, Bendikssen A (2005)
    Oxidative and nonoxidative glucose disposal in elderly vs younger men with similar and smaller body mass indices and waist circumferences
    Metabolism, 54 (6), 748-55
    DOI 10.1016/j.metabol.2005.01.016, PubMed 15931609
  2. Büchler M, Chadban S, Cole E, Midtvedt K, Thervet E, Prestele H, Keown P (2005)
    Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases
    Nephrol Dial Transplant, 21 (1), 197-202
    DOI 10.1093/ndt/gfi113, PubMed 16204301
  3. Corsini A, Holdaas H (2005)
    Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation
    Ren Fail, 27 (3), 259-73
    DOI 10.1081/JDI-200056623, PubMed 15957541
  4. Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators (2005)
    Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial
    Transplantation, 79 (2), 205-12
    DOI 10.1097/01.tp.0000147338.34323.12, PubMed 15665769
  5. Fellström B, Jardine AG, Soveri I, Cole E, Grönhagen-Riska C, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H, Assessment of Lescol in Renal Transplantation trial (2005)
    Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial
    Transplantation, 79 (9), 1160-3
    DOI 10.1097/01.tp.0000160764.35083.b8, PubMed 15880062
  6. Fellström B, Jardine AG, Soveri I, Cole E, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H, ALERT Study Group (2005)
    Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation
    Am J Transplant, 5 (8), 1986-91
    DOI 10.1111/j.1600-6143.2005.00983.x, PubMed 15996249
  7. Fellström B, Zannad F, Schmieder R, Holdaas H, Jardine A, Rose H, Wilpshaar W, AURORA Study Group (2005)
    Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study
    Curr Control Trials Cardiovasc Med, 6 (1), 9
    DOI 10.1186/1468-6708-6-9, PubMed 15910680
  8. Hermann M, Asberg A, Christensen H, Reubsaet JL, Holdaas H, Hartmann A (2005)
    Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients
    Eur J Clin Pharmacol, 61 (1), 59-62
    DOI 10.1007/s00228-004-0874-5, PubMed 15711834
  9. Hjelmesaeth J, Asberg A, Müller F, Hartmann A, Jenssen T (2005)
    New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection
    Curr Diabetes Rev, 1 (1), 1-10
    PubMed 18220577
  10. Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
    Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
    Nephrol Dial Transplant, 20 (11), 2311-5
    DOI 10.1093/ndt/gfi033, PubMed 16046502
  11. Hobbs FD, Gensini G, Mancini GB, Manolis AJ, Bauer B, Böhler S, Genest J, Feldman R, Harvey P, Jenssen TG, Metcalfe M, da Silva PM, JEWEL Study Group (2005)
    Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)
    Int J Cardiol, 110 (2), 242-50
    DOI 10.1016/j.ijcard.2005.10.017, PubMed 16338012
  12. Holdaas H (2005)
    Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy?
    Am J Cardiovasc Drugs, 5 (4), 255-69
    DOI 10.2165/00129784-200505040-00005, PubMed 15984908
  13. Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2005)
    Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study
    Am J Transplant, 5 (12), 2929-36
    DOI 10.1111/j.1600-6143.2005.01105.x, PubMed 16303007
  14. Holdaas H, Fellström B, Jardine AG, ALERT Study Group (2005)
    Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial
    Am J Transplant, 5 (6), 1574-5
    DOI 10.1111/j.1600-6143.2005.00909.x, PubMed 15888072
  15. Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group (2005)
    Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation
    Nephrol Dial Transplant, 20 (5), 974-80
    DOI 10.1093/ndt/gfh735, PubMed 15784644
  16. Jardine AG, Fellström B, Logan JO, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Pedersen T, Holdaas H (2005)
    Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study
    Am J Kidney Dis, 46 (3), 529-36
    DOI 10.1053/j.ajkd.2005.05.014, PubMed 16129216
  17. Jenssen T (2005)
    The issue of measuring microalbuminuria
    Scand J Clin Lab Invest, 65 (6), 437-8
    DOI 10.1080/00365510500208308, PubMed 16179275
  18. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG (2005)
    Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment
    J Clin Endocrinol Metab, 91 (1), 145-53
    DOI 10.1210/jc.2005-1775, PubMed 16263815
  19. Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    Blood, 107 (5), 2022-9
    DOI 10.1182/blood-2005-05-2016, PubMed 16269620
  20. Lemahieu WP, Hermann M, Asberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD (2005)
    Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus
    Am J Transplant, 5 (9), 2236-43
    DOI 10.1111/j.1600-6143.2005.01005.x, PubMed 16095503
  21. Lindhardt TB, Abedini S, Olesen RM, Haunsø S, Gadsbøll N (2005)
    Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris
    Cardiology, 105 (1), 17-21
    DOI 10.1159/000088266, PubMed 16166774
  22. Midtvedt K (2005)
    [Infections in immunosuppressed children]
    Tidsskr Nor Laegeforen, 125 (13), 1884; author reply 1884
    PubMed 16012580
  23. Nashan B, Bock A, Bosmans JL, Budde K, Fijter H, Jaques B, Johnston A, Lück R, Midtvedt K, Pallardó LM, Ready A, Salamé E, Salizzoni M, Suarez F, Thervet E (2005)
    Use of Neoral C monitoring: a European consensus
    Transpl Int, 18 (7), 768-78
    DOI 10.1111/j.1432-2277.2005.00151.x, PubMed 15948854
  24. Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, Russ G, Grinyó JM, Stallone G, Hartmann A, Pinto JR, Chapman J, Burke JT, Brault Y, Neylan JF, Rapamune Maintenance Regimen Study Group (2005)
    Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
    Transpl Int, 18 (1), 22-8
    DOI 10.1111/j.1432-2277.2004.00052.x, PubMed 15612979
  25. Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyó JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF, Rapamune Maintenance Regimen Study Group (2005)
    Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function
    Transplantation, 80 (9), 1204-11
    DOI 10.1097/01.tp.0000178393.78084.9b, PubMed 16314787
  26. Sagedal S, Hartmann A, Osnes K, Bjørnsen S, Torremocha J, Fauchald P, Kofstad J, Brosstad F (2005)
    Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin
    Nephrol Dial Transplant, 21 (2), 444-9
    DOI 10.1093/ndt/gfi203, PubMed 16234293
  27. Toft I, Jenssen T (2005)
    Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production
    Scand J Clin Lab Invest, 65 (4), 307-20
    DOI 10.1080/00365510510025692, PubMed 16076686
  28. Voytovich M, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2005)
    Short-term rosiglitazone treatment in renal transplant recipients - Reply
    Nephrol. Dial. Transplant., 20 (7), 1512
  29. Witczak B, Hartmann A, Svennevig JL (2005)
    Multiple risk assessment of cardiovascular surgery in chronic renal failure patients
    Ann Thorac Surg, 79 (4), 1297-302
    DOI 10.1016/j.athoracsur.2004.09.010, PubMed 15797066
  30. Øien CM, Reisaeter AV, Leivestad T, Pfeffer P, Fauchald P, Os I (2005)
    Gender imbalance among donors in living kidney transplantation: the Norwegian experience
    Nephrol Dial Transplant, 20 (4), 783-9
    DOI 10.1093/ndt/gfh696, PubMed 15701672
  31. Aasebø W, Midtvedt K, Hartmann A, Stavem K (2005)
    Predictors of health-related quality of life in hypertensive recipients following renal transplantation
    Clin Transplant, 19 (6), 756-62
    DOI 10.1111/j.1399-0012.2005.00416.x, PubMed 16313321

Publications 2004

  1. Asberg A, Holdaas H (2004)
    Fluvastatin and fluvastatin extended release: a clinical and safety profile
    Expert Rev Cardiovasc Ther, 2 (5), 641-52
    DOI 10.1586/14779072.2.5.641, PubMed 15350166
  2. Aune E, Steen-Hansen JE, Hjelmesaeth J, Otterstad JE (2004)
    [Prehospital diagnosis and treatment of acute myocardial infarction in Vestfold]
    Tidsskr Nor Laegeforen, 124 (23), 3058-60
    PubMed 15586187
  3. Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators (2004)
    Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
    Kidney Int, 66 (4), 1549-55
    DOI 10.1111/j.1523-1755.2004.00919.x, PubMed 15458450
  4. Hartmann A, Midtvedt K, Witczak B (2004)
    [Kidney injuries and kidney failure caused by drugs]
    Tidsskr Nor Laegeforen, 124 (21), 2765-6
    PubMed 15534671
  5. Hermann M, Asberg A, Christensen H, Holdaas H, Hartmann A, Reubsaet JL (2004)
    Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients
    Clin Pharmacol Ther, 76 (4), 388-91
    DOI 10.1016/j.clpt.2004.07.008, PubMed 15470339
  6. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T (2004)
    Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
    Diabetologia, 47 (9), 1550-6
    DOI 10.1007/s00125-004-1499-z, PubMed 15338129
  7. Hunderi OH, Hovda KE, Lie B, Listerud S, Hartmann A, Jacobsen D (2004)
    [Methanol poisoning in Norway 2002]
    Tidsskr Nor Laegeforen, 124 (24), 3199-202
    PubMed 15608765
  8. Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR, ALERT Study Investigators (2004)
    fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study
    Am J Transplant, 4 (6), 988-95
    DOI 10.1111/j.1600-6143.2004.00445.x, PubMed 15147434
  9. Jørgensen L, Jenssen T, Joakimsen O, Heuch I, Ingebretsen OC, Jacobsen BK (2004)
    Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromsø study
    Circulation, 110 (4), 466-70
    DOI 10.1161/01.CIR.0000136809.55141.3B, PubMed 15249512
  10. Kahra T, Jenssen T, Løvik A (2004)
    Dietary intakes differ between renal transplant recipients living in patient hotels versus home
    J Ren Nutr, 14 (2), 101-8
    DOI 10.1053/j.jm.2004.01.010, PubMed 15060875
  11. Midtvedt K (2004)
    Therapeutic drug monitoring of cyclosporine
    Transplant Proc, 36 (2 Suppl), 430S-433S
    DOI 10.1016/j.transproceed.2004.01.025, PubMed 15041380
  12. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T (2004)
    Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal
    J Am Soc Nephrol, 15 (12), 3233-9
    DOI 10.1097/01.ASN.0000145435.80005.1E, PubMed 15579527
  13. Sagedal S, Hartmann A (2004)
    Low molecular weight heparins as thromboprophylaxis in patients undergoing hemodialysis/hemofiltration or continuous renal replacement therapies
    Eur J Med Res, 9 (3), 125-30
    PubMed 15096322
  14. Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
    Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
    Kidney Int, 66 (1), 329-37
    DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441
  15. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF (2004)
    Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease
    Eur Heart J, 25 (5), 363-70
    DOI 10.1016/j.ehj.2003.12.003, PubMed 15033247
  16. Sund S, Grimm P, Reisaeter AV, Hovig T (2004)
    Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis
    Nephrol Dial Transplant, 19 (11), 2838-45
    DOI 10.1093/ndt/gfh490, PubMed 15385637
  17. Sund S, Reisaeter AV, Scott H, Mollnes TE, Hovig T (2004)
    Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies
    Clin Nephrol, 62 (2), 121-30
    DOI 10.5414/cnp62121, PubMed 15356969
  18. Svartberg J, Jenssen T, Sundsfjord J, Jorde R (2004)
    The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromsø Study
    Diabetes Metab, 30 (1), 29-34
    DOI 10.1016/S1262-3636(07)70086-1, PubMed 15029095
  19. Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2004)
    Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients
    Nephrol Dial Transplant, 20 (2), 413-8
    DOI 10.1093/ndt/gfh641, PubMed 15615809
  20. Zykova SN, Svartberg J, Seljelid R, Iversen H, Lund A, Svistounov DN, Jenssen TG (2004)
    Release of TNF-alpha from in vitro-stimulated monocytes is negatively associated with serum levels of apolipoprotein B in patients with type 2 diabetes
    Scand J Immunol, 60 (5), 535-42
    DOI 10.1111/j.0300-9475.2004.01509.x, PubMed 15541048

Publications 2003

  1. Asberg A, Holdaas H, Jardine AG, Edvardsen C, Hartmann A (2003)
    Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation
    Clin Transplant, 17 (4), 385-90
    DOI 10.1034/j.1399-0012.2003.00063.x, PubMed 12868997
  2. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, März W, Reckless JP, Stein EA (2003)
    Risk for myopathy with statin therapy in high-risk patients
    Arch Intern Med, 163 (5), 553-64
    DOI 10.1001/archinte.163.5.553, PubMed 12622602
  3. Bryhni B, Jenssen TG, Olafsen K, Eikrem JH (2003)
    Age or waist as determinant of insulin action?
    Metabolism, 52 (7), 850-7
    DOI 10.1016/S0026-0495(03)00100-8, PubMed 12870160
  4. Fellström BC, Holdaas H, Jardine AG (2003)
    Why do we need a statin trial in hemodialysis patients?
    Kidney Int Suppl (84), S204-6
    DOI 10.1046/j.1523-1755.63.s84.10.x, PubMed 12694345
  5. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A (2003)
    A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients
    Nephrol Dial Transplant, 18 (10), 2154-9
    DOI 10.1093/ndt/gfg338, PubMed 13679495
  6. Hartmann A, Fauchald P, Westlie L, Brekke IB, Holdaas H (2003)
    The risk of living kidney donation
    Nephrol Dial Transplant, 18 (5), 871-3
    DOI 10.1093/ndt/gfg069, PubMed 12686656
  7. Hjelmesaeth J, Jenssen T, Hagen M, Egeland T, Hartmann A (2003)
    Determinants of insulin secretion after renal transplantation
    Metabolism, 52 (5), 573-8
    DOI 10.1053/meta.2003.50092, PubMed 12759886
  8. Hjelmesaeth J, Jenssen T, Hartmann A (2003)
    Diagnosing PTDM
    Transplantation, 75 (10), 1761
    DOI 10.1097/01.TP.0000064543.07931.F6, PubMed 12777872
  9. Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2003)
    Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
    Lancet, 361 (9374), 2024-31
    DOI 10.1016/S0140-6736(03)13638-0, PubMed 12814712
  10. Holdaas H, Jardine A (2003)
    Acute renal allograft rejections, a role for statins?
    Minerva Urol Nefrol, 55 (2), 111-9
    PubMed 12847415
  11. Jakobsen A, Holdaas H, Leivestad T (2003)
    Ethics and safety of living kidney donation
    Transplant Proc, 35 (3), 1177-8
    DOI 10.1016/s0041-1345(03)00136-2, PubMed 12947899
  12. Mandla R, Line PD, Midtvedt K, Bergan S (2003)
    Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients
    Ther Drug Monit, 25 (3), 407-14
    DOI 10.1097/00007691-200306000-00025, PubMed 12766573
  13. Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T (2003)
    C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Transplantation, 76 (8), 1236-8
    DOI 10.1097/01.TP.0000085046.39523.D5, PubMed 14578761
  14. Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL, Leivestad T, Brekke IB (2003)
    Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection
    Clin Transplant, 17 (1), 69-74
    DOI 10.1034/j.1399-0012.2003.02105.x, PubMed 12588325
  15. Otterstad JE, Hjelmesaeth J, Hoffstad T (2003)
    [Percutaneous coronary intervention]
    Tidsskr Nor Laegeforen, 123 (5), 685
    PubMed 12683209
  16. Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
    Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
    Nephrol Dial Transplant, 18 (9), 1899-908
    DOI 10.1093/ndt/gfg302, PubMed 12937241
  17. Schramm W, Bergrem H, Cromme P, Feest T, Borch-Johnsen K, Feldt-Rasmussen B, Landgraf R (2003)
    First referral of diabetic patients to a nephrologist
    Diabet Med, 20 (8), 689-90
    PubMed 12873302
  18. Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal Ø, Mollnes TE (2003)
    Complement activation in early protocol kidney graft biopsies after living-donor transplantation
    Transplantation, 75 (8), 1204-13
    DOI 10.1097/01.TP.0000062835.30165.2C, PubMed 12717204
  19. Toft I, Lindal S, Bønaa KH, Jenssen T (2003)
    Quantitative measurement of muscle fiber composition in a normal population
    Muscle Nerve, 28 (1), 101-8
    DOI 10.1002/mus.10373, PubMed 12811780
  20. Westlie L, Leivestad T, Holdaas H, Lien B, Hartmann A, Fauchald P (2003)
    [Is current practice concerning living donors in kidney transplantations acceptable?]
    Tidsskr Nor Laegeforen, 123 (8), 1063-5
    PubMed 12760222
  21. Westlie L, Leivestad T, Holdaas H, Lien B, Meyer K, Fauchald P (2003)
    [How are living kidney donors doing?]
    Tidsskr Nor Laegeforen, 123 (8), 1060-2
    PubMed 12760221
  22. Westlie L, Leivestad T, Holdaas H, Lien B, Meyer K, Fauchald P (2003)
    Report from the Norwegian National Hospitals Living Donor Registry: one-year data, January 1, 2002
    Transplant Proc, 35 (2), 777-8
    DOI 10.1016/s0041-1345(03)00039-3, PubMed 12644132
  23. Witczak B, Hartmann A, Leivestad T, Øyen O, Svennevig J (2003)
    Cardiovascular surgery in renal failure patients with or without subsequent renal transplantation
    Transplant Proc, 35 (2), 798-800
    DOI 10.1016/s0041-1345(03)00075-7, PubMed 12644143

Publications 2002

  1. Bjorang O, Tveitan H, Midtvedt K, Broch LU, Scott H, Andresen PA (2002)
    Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient
    Nephrol Dial Transplant, 17 (11), 2023-5
    DOI 10.1093/ndt/17.11.2023, PubMed 12401867
  2. Cole E, Midtvedt K, Johnston A, Pattison J, O'Grady C (2002)
    Recommendations for the implementation of Neoral C(2) monitoring in clinical practice
    Transplantation, 73 (9 Suppl), S19-22
    DOI 10.1097/00007890-200205151-00004, PubMed 12023609
  3. Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
    [Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
    Tidsskr Nor Laegeforen, 122 (22), 2180-3
    PubMed 12426892
  4. Heldal K, Midtvedt K (2002)
    [Licorice--not just candy]
    Tidsskr Nor Laegeforen, 122 (8), 774-6
    PubMed 12092066
  5. Hjelmesaeth J, Carlsson PO (2002)
    Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study
    Lancet, 359 (9324), 2201-2; author reply 2203-4
    DOI 10.1016/S0140-6736(02)09074-8, PubMed 12091007
  6. Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T (2002)
    The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation
    Clin Transplant, 16 (6), 389-96
    DOI 10.1034/j.1399-0012.2002.02059.x, PubMed 12437616
  7. Hjelmesaeth J, Jenssen T, Egeland T, Hagen M, Hartmann A (2002)
    Response to Montori et al. Post-transplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management of the disease
    Diabetes Care, 25 (9), 1667; discussion 1667-8
    DOI 10.2337/diacare.25.9.1667, PubMed 12196456
  8. Hjelmesaeth J, Jenssen T, Hartmann A (2002)
    Diagnosing PTDM
    Transplantation, 74 (4), 579
    DOI 10.1097/00007890-200208270-00027, PubMed 12352924
  9. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2002)
    Insulin resistance after renal transplantation
    Diabetes Care, 25 (7), 1260-1261
  10. Holdaas H, Julian D (2002)
    The use of statins after solid organ transplantation
    Nephrol Dial Transplant, 17 (8), 1537
    DOI 10.1093/ndt/17.8.1537, PubMed 12147814
  11. Midtvedt K, Hartmann A (2002)
    Hypertension after kidney transplantation: are treatment guidelines emerging?
    Nephrol Dial Transplant, 17 (7), 1166-9
    DOI 10.1093/ndt/17.7.1166, PubMed 12105236
  12. Midtvedt K, Hartmann A (2002)
    Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril"
    Transplantation, 74 (1), UNSP 0041-1337/02/7401-139/0-140
  13. Os I, Stenehjem A, Høieggen A, Draganov B, Jenssen T, Holdaas H (2002)
    [Type 2 diabetes and nephropathy--new studies, new treatment strategies?]
    Tidsskr Nor Laegeforen, 122 (9), 918-20
    PubMed 12082835
  14. Osterby R, Hartmann A, Nyengaard JR, Bangstad HJ (2002)
    Development of renal structural lesions in type-1 diabetic patients with microalbuminuria. Observations by light microscopy in 8-year follow-up biopsies
    Virchows Arch, 440 (1), 94-101
    DOI 10.1007/s004280100485, PubMed 11942582
  15. Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
    The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
    Am J Transplant, 2 (9), 850-6
    DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291
  16. Thorgersen EB, Øfsti AM, Nyheim T, Abedini S (2002)
    [Acute groin pain and femoral nerve deficit in a warfarin treated patient]
    Tidsskr Nor Laegeforen, 122 (24), 2360-1
    PubMed 12448249
  17. Toft I, Bønaa KH, Eikrem J, Bendiksen AL, Iversen H, Jenssen T (2002)
    Microalbuminuria in hypertension is not a determinant of insulin resistance
    Kidney Int, 61 (4), 1445-52
    DOI 10.1046/j.1523-1755.2002.00286.x, PubMed 11918751
  18. Toft I, Gerich JE, Jenssen T (2002)
    Autoregulation of endogenous glucose production during hyperglucagonemia
    Metabolism, 51 (9), 1128-34
    DOI 10.1053/meta.2002.34702, PubMed 12200756
  19. van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE (2002)
    Disturbances in beta-cell function in impaired fasting glycemia
    Diabetes, 51 Suppl 1, S265-70
    DOI 10.2337/diabetes.51.2007.s265, PubMed 11815491

Publications 2001

  1. Asberg A, Hartmann A, Fjeldså E, Bergan S, Holdaas H (2001)
    Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients
    Am J Transplant, 1 (4), 382-6
    DOI 10.1034/j.1600-6143.2001.10415.x, PubMed 12099384
  2. Asberg A, Hartmann A, Fjeldså E, Holdaas H (2001)
    Atorvastatin improves endothelial function in renal-transplant recipients
    Nephrol Dial Transplant, 16 (9), 1920-4
    DOI 10.1093/ndt/16.9.1920, PubMed 11522880
  3. Asberg A, Midtvedt K, Vassbotn T, Hartmann A (2001)
    Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients
    Nephrol Dial Transplant, 16 (7), 1465-70
    DOI 10.1093/ndt/16.7.1465, PubMed 11427642
  4. Gøransson LG, Bergrem H (2001)
    Consequences of late referral of patients with end-stage renal disease
    J Intern Med, 250 (2), 154-9
    DOI 10.1046/j.1365-2796.2001.00869.x, PubMed 11489065
  5. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrøm J, Fauchald P (2001)
    Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance
    Nephrol Dial Transplant, 16 (4), 829-35
    DOI 10.1093/ndt/16.4.829, PubMed 11274282
  6. Hjelmesaeth J, Hartmann A, Midtvedt K, Aakhus S, Stenstrøm J, Mørkrid L, Egeland T, Tordarson H, Fauchald P (2001)
    Metabolic cardiovascular syndrome after renal transplantation
    Nephrol Dial Transplant, 16 (5), 1047-52
    DOI 10.1093/ndt/16.5.1047, PubMed 11328915
  7. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2001)
    Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy
    Diabetes Care, 24 (12), 2121-6
    DOI 10.2337/diacare.24.12.2121, PubMed 11723094
  8. Holdaas H, Fellström B, Holme I, Nyberg G, Fauchald P, Jardine A, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Weinreich T, Olsson AG, Pedersen TR, Benghozi R, Hartmann A, ALERT Study Group. Assessment of Lescol in Renal Transplantation (2001)
    Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data
    J Cardiovasc Risk, 8 (2), 63-71
    DOI 10.1097/00043798-200104000-00002, PubMed 11324372
  9. Holdaas H, Jardine AG, Wheeler DC, Brekke IB, Conlon PJ, Fellstrøm B, Hammad A, Holme I, Isoniemi H, Moore R, Rowe PA, Sweny P, Talbot DA, Wadstrøm J, Østraat Ø (2001)
    Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial
    Kidney Int, 60 (5), 1990-7
    DOI 10.1046/j.1523-1755.2001.00010.x, PubMed 11703619
  10. Jenssen T (2001)
    [Revised national budget and peritoneal dialysis--all that glitters is not gold]
    Tidsskr Nor Laegeforen, 121 (17), 2094
    PubMed 11875911
  11. Kolstad O, Jenssen TG, Ingebretsen OC, Vinnars E, Revhaug A (2001)
    Combination of recombinant human growth hormone and glutamine-enriched total parenteral nutrition to surgical patients: effects on circulating amino acids
    Clin Nutr, 20 (6), 503-10
    DOI 10.1054/clnu.2001.0478, PubMed 11883998
  12. Linde T, Ekberg H, Forslund T, Furuland H, Holdaas H, Nyberg G, Tydén G, Wahlberg J, Danielson BG (2001)
    The use of pretransplant erythropoietin to normalize hemoglobin levels has no deleterious effects on renal transplantation outcome
    Transplantation, 71 (1), 79-82
    DOI 10.1097/00007890-200101150-00013, PubMed 11211199
  13. Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H (2001)
    Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril
    Transplantation, 72 (11), 1787-92
    DOI 10.1097/00007890-200112150-00013, PubMed 11740389
  14. Midtvedt K, Hartmann A, Holdaas H, Fauchald P (2001)
    Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial
    Clin Transplant, 15 (6), 426-31
    DOI 10.1034/j.1399-0012.2001.150611.x, PubMed 11737121
  15. Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001)
    Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study
    Transplantation, 72 (1), 107-11
    DOI 10.1097/00007890-200107150-00021, PubMed 11468543
  16. Reisaeter AV, Hartmann A (2001)
    Risk factors and incidence of posttransplant diabetes mellitus
    Transplant Proc, 33 (5A Suppl), 8S-18S
    DOI 10.1016/s0041-1345(01)02229-1, PubMed 11498199
  17. Witczak BJ, Asberg A, Hartmann A (2001)
    [Acute dialysis-dependent renal failure at the Rikshospital in 1998]
    Tidsskr Nor Laegeforen, 121 (10), 1216-9
    PubMed 11402747

Publications 2000

  1. Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I (2000)
    [Prevention of cardiovascular disease in type 2 diabetes]
    Tidsskr Nor Laegeforen, 120 (21), 2554-9
    PubMed 11070996
  2. Grill V, Claudi T, Følling I, Jenssen T, Hanssen K, Jervell J (2000)
    [New diagnostic criteria for diabetes mellitus--why?]
    Tidsskr Nor Laegeforen, 120 (16), 1876-7
    PubMed 10925616
  3. Hartmann A, Halvorsen CE, Jenssen T, Bjørneklett A, Brekke IB, Bakke SJ, Hirschberg H, Tønjum T, Gaustad P (2000)
    Intracerebral abscess caused by Nocardia otitidiscaviarum in a renal transplant patient--cured by evacuation plus antibiotic therapy
    Nephron, 86 (1), 79-83
    DOI 10.1159/000045716, PubMed 10971157
  4. Hjalmarsen A, Viitanen M, Jenssen T, Jorde R, Johansen O (2000)
    Plasma beta-endorphin concentrations are increased in chronic obstructive pulmonary disease patients
    Scand J Clin Lab Invest, 60 (6), 501-6
    DOI 10.1080/003655100448482, PubMed 11129066
  5. Hjelmesaeth J (2000)
    [New diagnostic criteria for diabetes mellitus]
    Tidsskr Nor Laegeforen, 120 (18), 2193
    PubMed 11006749
  6. Hjelmesaeth J, Hartmann A (2000)
    Risk for posttransplant diabetes mellitus with current immunosuppressive medications
    Am J Kidney Dis, 35 (3), 562
    DOI 10.1016/S0272-6386(00)70217-4, PubMed 10692289
  7. Jindal RM, Hjelmesaeth J (2000)
    Impact and management of posttransplant diabetes mellitus
    Transplantation, 70 (11 Suppl), SS58-63
    PubMed 11152233
  8. Midtvedt K, Neumayer HH (2000)
    Management strategies for posttransplant hypertension
    Transplantation, 70 (11 Suppl), SS64-9
    PubMed 11152234
  9. Skeie S, Bergrem H (2000)
    [Use of information technology in quality development of diabetic care]
    Tidsskr Nor Laegeforen, 120 (16), 1899-902
    PubMed 10925622
  10. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Häring H, Fritsche A, Gerich J (2000)
    Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes
    Diabetes Care, 23 (9), 1440-1
    DOI 10.2337/diacare.23.9.1440, PubMed 10977054
  11. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J (2000)
    Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity
    Diabetes Care, 23 (3), 295-301
    DOI 10.2337/diacare.23.3.295, PubMed 10868854
  12. van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE (2000)
    Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia
    Metabolism, 49 (10), 1318-25
    DOI 10.1053/meta.2000.9526, PubMed 11079822
  13. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R (2000)
    Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice
    Diabetes, 49 (9), 1451-8
    DOI 10.2337/diabetes.49.9.1451, PubMed 10969828

Publications 1999

  1. Asberg A, Attramadal H, Midtvedt K, Sund S, Hartmann A, Berg KJ (1999)
    Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression
    Transplantation, 67 (7), 1056-60
    DOI 10.1097/00007890-199904150-00020, PubMed 10221493
  2. Halvorsen CE, Hartmann A, Jenssen T, Fauchald P, Brekke IB, Jakobsen JA (1999)
    Salvage of a renal graft by percutaneous transluminal angioplasty of the occluding transplant artery
    Nephrol Dial Transplant, 14 (9), 2231-3
    DOI 10.1093/ndt/14.9.2231, PubMed 10489241
  3. Hjelmesaeth J, Hartmann A (1999)
    Insulin resistance in patients with adult polycystic kidney disease
    Nephrol Dial Transplant, 14 (10), 2521-2
    DOI 10.1093/ndt/14.10.2521, PubMed 10528694
  4. Hjelmesaeth J, Midtvedt K, Aakhus S, Hartmann A (1999)
    [Cardiovascular disease after kidney transplantation]
    Tidsskr Nor Laegeforen, 119 (25), 3784-8
    PubMed 10574058
  5. Jardine A, Holdaas H (1999)
    Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience
    J Clin Pharm Ther, 24 (6), 397-408
    DOI 10.1046/j.1365-2710.1999.00252.x, PubMed 10651972
  6. Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E (1999)
    The role of HLA matching in renal transplantation: experience from one center
    Rev Immunogenet, 1 (3), 343-50
    PubMed 11256425
  7. Midtvedt K (1999)
    [Infections in renal transplant recipients in Norway]
    Tidsskr Nor Laegeforen, 119 (24), 3621-3
    PubMed 10563182
  8. Reisaeter AV (1999)
    [Kidney transplantation in Norway--a historical perspective]
    Tidsskr Nor Laegeforen, 119 (21), 3163-6
    PubMed 10522485
  9. Sund S, Reisaeter AV, Fauchald P, Bentdal O, Hall KS, Hovig T (1999)
    Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years
    Nephrol Dial Transplant, 14 (10), 2445-54
    DOI 10.1093/ndt/14.10.2445, PubMed 10528671
  10. Toft I, Bønaa KH, Lindal S, Berg TJ, Jenssen T (1999)
    Population-based study of the relationship among muscle morphology, insulin action, and hypertension
    Am J Hypertens, 12 (12 Pt 1-2), 1209-16
    DOI 10.1016/s0895-7061(99)00157-0, PubMed 10619584

Publications 1998

  1. Balteskard L, Unneberg K, Mjaaland M, Jenssen TG, Revhaug A (1998)
    Growth hormone and insulinlike growth factor 1 promote intestinal uptake and hepatic release of glutamine in sepsis
    Ann Surg, 228 (1), 131-9
    DOI 10.1097/00000658-199807000-00019, PubMed 9671077
  2. Balteskard L, Unneberg K, Mjaaland M, Sager G, Jenssen TG, Revhaug A (1998)
    Treatment with growth hormone and insulin-like growth factor-1 in septicemia: effects on carbohydrate metabolism
    Eur Surg Res, 30 (2), 79-94
    DOI 10.1159/000008562, PubMed 9565741
  3. Hjelmesaeth J, Hartmann A (1998)
    [Diabetic care in general practice]
    Tidsskr Nor Laegeforen, 118 (2), 278
    PubMed 9485629
  4. Holdaas H, Hartmann A, Berg KJ, Lund K, Fauchald P (1998)
    Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy
    Nephrol Dial Transplant, 13 (12), 3096-102
    DOI 10.1093/ndt/13.12.3096, PubMed 9870472
  5. Lehne G, Nordal KP, Midtvedt K, Goggin T, Brosstad F (1998)
    Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction
    Thromb Haemost, 79 (6), 1119-25
    PubMed 9657435
  6. Midtvedt K (1998)
    [Clostridium difficile-associated diarrhea treated with homologous feces]
    Tidsskr Nor Laegeforen, 118 (11), 1758
    PubMed 9621767
  7. Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL (1998)
    Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients
    Nephrol Dial Transplant, 13 (2), 427-31
    DOI 10.1093/oxfordjournals.ndt.a027841, PubMed 9509457
  8. Midtvedt K, Hartmann A, Midtvedt T, Brekke IB (1998)
    Routine perioperative antibiotic prophylaxis in renal transplantation
    Nephrol Dial Transplant, 13 (7), 1637-41
    DOI 10.1093/ndt/13.7.1637, PubMed 9681704
  9. Midtvedt K, Hartmann A, Sund S (1998)
    Can a diagnosis of renal allograft rejection be based on histology alone?
    Clin Transplant, 12 (4), 300-2
    PubMed 9686323
  10. Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
    A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
    Transplantation, 66 (4), 523-8
    DOI 10.1097/00007890-199808270-00018, PubMed 9734498
  11. Reisaeter AV, Thorsby E, Brinchmann JE (1998)
    Allospecific helper T-lymphocyte repertoire in monozygotic twins
    Scand J Immunol, 47 (4), 381-7
    PubMed 9600321
  12. Sund S, Reisaeter AV, Scott H, Fauchald P, Bentdal O, Sødal G, Hovig T (1998)
    Morphological studies of baseline needle biopsies from living donor kidneys: light microscopic, immunohistochemical and ultrastructural findings
    APMIS, 106 (11), 1017-34
    DOI 10.1111/j.1699-0463.1998.tb00254.x, PubMed 9890263
  13. Toft I, Bønaa KH, Jenssen T (1998)
    Insulin resistance in hypertension is associated with body fat rather than blood pressure
    Hypertension, 32 (1), 115-22
    DOI 10.1161/01.HYP.32.1.115, PubMed 9674647
  14. Toft I, Bønaa KH, Lindal S, Jenssen T (1998)
    Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance
    Metabolism, 47 (7), 848-54
    DOI 10.1016/S0026-0495(98)90125-1, PubMed 9667234

Publications 1997

  1. Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrøm J, Leivestad T, Egeland T, Fauchald P (1997)
    Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age
    Transplantation, 64 (7), 979-83
    DOI 10.1097/00007890-199710150-00008, PubMed 9381545
  2. Midtvedt K, Hartmann A, Brekke IB, Lyngdal PT, Bentdal O, Haugen G (1997)
    Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment
    Nephrol Dial Transplant, 12 (12), 2764-5
    DOI 10.1093/ndt/12.12.2764, PubMed 9430893
  3. Perriello G, Nurjhan N, Stumvoll M, Bucci A, Welle S, Dailey G, Bier DM, Toft I, Jenssen TG, Gerich JE (1997)
    Regulation of gluconeogenesis by glutamine in normal postabsorptive humans
    Am J Physiol, 272 (3 Pt 1), E437-45
    DOI 10.1152/ajpendo.1997.272.3.E437, PubMed 9124550
  4. Reisaeter AV, Leivestad T, Fauchald P, Brekke I, Thorsby E (1997)
    Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients
    Transplant Proc, 29 (7), 3099-100
    DOI 10.1016/s0041-1345(97)00798-7, PubMed 9365682
  5. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Birkeland KI, Jenssen T (1997)
    Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension
    Arterioscler Thromb Vasc Biol, 17 (3), 553-9
    DOI 10.1161/01.ATV.17.3.553, PubMed 9102176
  6. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T (1997)
    Fibrinolytic function after dietary supplementation with omega3 polyunsaturated fatty acids
    Arterioscler Thromb Vasc Biol, 17 (5), 814-9
    DOI 10.1161/01.ATV.17.5.814, PubMed 9157942
  7. Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Bjøro T, Revhaug A (1997)
    Both growth hormone and exogenous glutamine increase gastrointestinal glutamine uptake in trauma
    Ann Surg, 225 (1), 97-102
    DOI 10.1097/00000658-199701000-00011, PubMed 8998125

Publications 1996

  1. Hapnes R, Bergrem H (1996)
    Diabetic eye complications in a medium sized municipality in southwest Norway
    Acta Ophthalmol Scand, 74 (5), 497-500
    PubMed 8950402
  2. Hartmann A, Andereassen AK, Holdaas H, Simonsen S, Geiran O, Berg KJ (1996)
    Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients
    J Heart Lung Transplant, 15 (10), 972-9
    PubMed 8913913
  3. Midtvedt K, Hartmann A, Bentdal O, Brekke IB, Fauchald P (1996)
    Bilateral nephrectomy simultaneously with renal allografting does not alleviate hypertension 3 months following living-donor transplantation
    Nephrol Dial Transplant, 11 (10), 2045-9
    DOI 10.1093/oxfordjournals.ndt.a027094, PubMed 8918720
  4. Midtvedt K, Stokke ES, Hartmann A (1996)
    Successful long-term treatment of post-transplant erythrocytosis with losartan
    Nephrol Dial Transplant, 11 (12), 2495-7
    DOI 10.1093/oxfordjournals.ndt.a027224, PubMed 9017632
  5. Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P (1996)
    Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection
    Transplantation, 62 (1), 38-42
    DOI 10.1097/00007890-199607150-00008, PubMed 8693541
  6. Nyberg G, Holdaas H, Brekke IB, Hartmenn A, Norden G, Olausson M, Osterby R (1996)
    Glomerular ultrastructure in kidneys transplanted simultaneously with a segmental pancreas to patients with type 1 diabetes
    Nephrol Dial Transplant, 11 (6), 1029-33
    PubMed 8671964
  7. Reisaeter AV, Brinchmann JE, Lundin KE, Thorsby E (1996)
    Monozygotic twins display differences in their allospecific cytotoxic T-cell repertoire
    Scand J Immunol, 44 (6), 638-42
    DOI 10.1046/j.1365-3083.1996.d01-357.x, PubMed 8972747
  8. Reisaeter AV, Thorsby E, Brinchmann JE (1996)
    Analysis of alloreactive helper T lymphocyte precursor frequencies. Influence of interleukin-2 produced by the stimulating cells
    J Immunol Methods, 189 (1), 65-72
    DOI 10.1016/0022-1759(95)00230-8, PubMed 8576581
  9. Reseland JE, Holm H, Jacobsen MB, Jenssen TG, Hanssen LE (1996)
    Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion
    J Nutr, 126 (3), 634-42
    DOI 10.1093/jn/126.3.634, PubMed 8598548
  10. Stumvoll M, Perriello G, Nurjhan N, Bucci A, Welle S, Jansson PA, Dailey G, Bier D, Jenssen T, Gerich J (1996)
    Glutamine and alanine metabolism in NIDDM
    Diabetes, 45 (7), 863-8
    DOI 10.2337/diab.45.7.863, PubMed 8666134
  11. Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Revhaug A (1996)
    Growth hormone pre-treatment combined with exogenous glutamine induced a postoperative shift from glucose to glutamine consumption in the gastrointestinal tract
    Clin Nutr, 15 (4), 165-70
    DOI 10.1016/S0261-5614(96)80235-4, PubMed 16844028

Publications 1995

  1. Bergrem H, Johansen KS (1995)
    Targets for glycated haemoglobin. Targets set reference points for clinic comparisons
    BMJ, 311 (6998), 189-90
    DOI 10.1136/bmj.311.6998.189c, PubMed 7613443
  2. Brekke IB, Bentdal O, Pfeffer P, Lien B, Sødal G, Holdaas H, Fauchald P, Jervell J (1995)
    [Pancreas transplantation. A 10-year material]
    Tidsskr Nor Laegeforen, 115 (6), 703-5
    PubMed 7900130
  3. Holdaas H, Hartmann A, Berg KJ, Langberg H, Blystad L, Fauchald P (1995)
    Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy
    J Intern Med, 237 (1), 63-71
    DOI 10.1111/j.1365-2796.1995.tb01141.x, PubMed 7830033
  4. Holdaas H, Hartmann A, Stenstrøm J, Dahl KJ, Borge M, Pfister P (1995)
    Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine
    Am J Cardiol, 76 (2), 102A-106A
    DOI 10.1016/s0002-9149(05)80028-1, PubMed 7604781
  5. JENSSEN T (1995)
    METHODOLOGICAL PROBLEMS IN EVALUATION OF SOCIAL REFORMS - EXEMPLIFIED BY DEINSTITUTIONALIZATION OF THE MENTALLY-RETARDED IN NORWAY
    Psychol. Rec., 45 (4), 535-563
  6. Johansen O, Jorde R, Tønnesen T, Jenssen T, Burhol PG, Reikerås O (1995)
    Effects of naloxone on glucagon and insulin concentrations after injection of endotoxin in rats
    Eur J Surg, 161 (9), 635-8
    PubMed 8541421
  7. Mjaaland M, Unneberg K, Jenssen TG, Bjøro T, Lindal S, Revhaug A (1995)
    Metabolic effects of two regimens of growth hormone given before operation in piglets
    Eur J Surg, 161 (9), 639-46
    PubMed 8541422
  8. Mjaaland M, Unneberg K, Jenssen TG, Revhaug A (1995)
    Experimental study to show that growth hormone treatment before trauma increases glutamine uptake in the intestinal tract
    Br J Surg, 82 (8), 1076-9
    DOI 10.1002/bjs.1800820823, PubMed 7648157
  9. Nurjhan N, Bucci A, Perriello G, Stumvoll M, Dailey G, Bier DM, Toft I, Jenssen TG, Gerich JE (1995)
    Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man
    J Clin Invest, 95 (1), 272-7
    DOI 10.1172/JCI117651, PubMed 7814625
  10. Perriello G, Jorde R, Nurjhan N, Stumvoll M, Dailey G, Jenssen T, Bier DM, Gerich JE (1995)
    Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle
    Am J Physiol, 269 (3 Pt 1), E443-50
    DOI 10.1152/ajpendo.1995.269.3.E443, PubMed 7573421
  11. PERRIELLO G, JORDE R, NURJHAN N, STUMVOLL M, DAILEY G, JENSSEN T, BIER DM, GERICH JE (1995)
    ESTIMATION OF GLUCOSE-ALANINE-LACTATE-GLUTAMINE CYCLES IN POSTABSORPTIVE HUMANS - ROLE OF SKELETAL-MUSCLE
    Am. J. Physiol.-Endocrinol. Metab., 269 (3), E443-E450
  12. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J (1995)
    Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative
    JAMA, 273 (23), 1855-61
    DOI 10.1001/jama.273.23.1855, PubMed 7776502
  13. Reisaeter AV, Leivestad T, Albrechtsen D, Holdaas H, Hartmann A, Sødal G, Flatmark A, Fauchald P (1995)
    Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients
    Transplantation, 60 (3), 242-8
    DOI 10.1097/00007890-199508000-00006, PubMed 7645036
  14. Reseland JE, Holm H, Jenssen T, Jacobsen MB, Hanssen LE (1995)
    Inhibitor-stimulated non-parallel pancreatic secretion in man: hormonal and neural regulation?
    Scand J Gastroenterol, 30 (1), 72-80
    DOI 10.3109/00365529509093239, PubMed 7701255
  15. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T (1995)
    Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial
    Ann Intern Med, 123 (12), 911-8
    DOI 10.7326/0003-4819-123-12-199512150-00003, PubMed 7486485
  16. Tonstad S, Holdaas H, Gørbitz C, Ose L (1995)
    Is dietary intervention effective in post-transplant hyperlipidaemia?
    Nephrol Dial Transplant, 10 (1), 82-5
    PubMed 7724035

Publications 1994

  1. Bentdal OH, Brekke IB, Lien B, Pfeffer PF, Sødal G, Hartmann A, Holdaas H, Nordal KP, Fauchald P (1994)
    Rapid development of cancer in both kidney grafts after transplantation from a donor with undiagnosed malignant disease
    Transplant Proc, 26 (3), 1763
    PubMed 8030123
  2. Cooper JG, Bergrem H, Lassen J (1994)
    [Hemolytic-uremic syndrome caused by verotoxin-producing Escherichia coli intestinal infection]
    Tidsskr Nor Laegeforen, 114 (27), 3179-81
    PubMed 7809868
  3. Gullestad L, Midtvedt K, Dolva LO, Norseth J, Kjekshus J (1994)
    The magnesium loading test: reference values in healthy subjects
    Scand J Clin Lab Invest, 54 (1), 23-31
    DOI 10.3109/00365519409086506, PubMed 8171268
  4. Gullestad L, Nes M, Rønneberg R, Midtvedt K, Falch D, Kjekshus J (1994)
    Magnesium status in healthy free-living elderly Norwegians
    J Am Coll Nutr, 13 (1), 45-50
    PubMed 8157853
  5. Hartmann A, Lund K, Holdaas H, Fauchald P, Reisaeter A, Berg KJ (1994)
    Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients
    J Am Soc Nephrol, 5 (6), 1385-90
    PubMed 7534496
  6. Hartmann A, Reisaeter A, Holdaas H, Rolfsen B, Fauchald P (1994)
    Accidental metabolic acidosis during hemodialysis
    Artif Organs, 18 (3), 214-7
    DOI 10.1111/j.1525-1594.1994.tb02178.x, PubMed 8185487
  7. Holdaas H, Andersson R, Fauchald P, Albrechtsen D (1994)
    [Infection in patients with organ transplants]
    Nord Med, 109 (6-7), 194-6
    PubMed 8015915
  8. JENSSEN T, NURJHAN N, PERRIELLO G, BUCCI A, TOFT I, GERICH J (1994)
    DETERMINATION OF [C-14] GLUTAMINE SPECIFIC ACTIVITY IN PLASMA
    J. Liq. Chromatogr., 17 (6), 1337-1348
  9. Reisaeter AV, Fauchald P, Leivestad T, Holdaas H, Hartmann A, Pfeffer P, Sødal G (1994)
    Plasma exchange in highly sensitized patients as induction therapy after renal transplantation
    Transplant Proc, 26 (3), 1758
    PubMed 8030121

Publications 1993

  1. Hjelmesaeth J, Rynning S, Halvorsen E, Otterstad JE, Vatne K, Nitter-Hauge S (1993)
    [Are the results of thallium scintigraphy and coronary angiography equivalent? An evaluation of thallium scintigraphies performed at Vestfold Central Hospital]
    Tidsskr Nor Laegeforen, 113 (27), 3342-5
    PubMed 8273057
  2. Midtvedt K (1993)
    [Urinary tract infections]
    Tidsskr Nor Laegeforen, 113 (5), 618-9
    PubMed 7794286
  3. Omdal R, Gøransson L, Bergrem H (1993)
    Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis
    Clin Rheumatol, 12 (2), 283-4
    DOI 10.1007/BF02231548, PubMed 8358998

Publications 1992

  1. Apeland T, Bergrem H, Berget M (1992)
    [Pregnant diabetics. A retrospective study of pregnancy and labor in women with type 1 diabetes in Sør-Rogaland 1982-90]
    Tidsskr Nor Laegeforen, 112 (19), 2520-3
    PubMed 1412260
  2. Fauchald P, Vatne K, Paulsen D, Brodahl U, Sødal G, Holdaas H, Berg KJ, Flatmark A (1992)
    Long-term clinical results of percutaneous transluminal angioplasty in transplant renal artery stenosis
    Nephrol Dial Transplant, 7 (3), 256-9
    DOI 10.1093/oxfordjournals.ndt.a092116, PubMed 1315000
  3. Hanssen KF, Jenssen T (1992)
    [Treatment of non-insulin dependent diabetes (type 2 diabetes mellitus)]
    Tidsskr Nor Laegeforen, 112 (7), 912-4
    PubMed 1557762
  4. Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke IB, Flatmark A (1992)
    Fifteen years' experience with renal transplantation in systemic amyloidosis
    Transpl Int, 5 (1), 15-8
    PubMed 1580980
  5. HAUGSTVEDT TK, VISTE A, EIDE GE, MAARTMANNMOE H, MYKING A, SOREIDE O, HANSEN O, ANDENAES K, SKJELDAL S, WESSELHOLST C, SOLHEIM K, OMLAND E, BERGAN A, GERNER T, STADAAS J, HARBITZ TB, LIAVAAG I, HOGNESTAD J, HAVIG O, LEIDAL O, UGGERUD R, NORBYE B, AASEN S, SVANE S, HOLME P et al. (1992)
    IS LAUREN HISTOPATHOLOGICAL CLASSIFICATION OF IMPORTANCE IN PATIENTS WITH STOMACH-CANCER - A NATIONAL EXPERIENCE
    Eur. J. Surg. Oncol., 18 (2), 124-130
  6. Holst N, Jenssen TG, Burhol PG (1992)
    Plasma concentrations of motilin and somatostatin are increased in late pregnancy and postpartum
    Br J Obstet Gynaecol, 99 (4), 338-41
    DOI 10.1111/j.1471-0528.1992.tb13735.x, PubMed 1349818
  7. Mitrakou A, Mokan M, Bolli G, Veneman T, Jenssen T, Cryer P, Gerich J (1992)
    Evidence against the hypothesis that hyperinsulinemia increases sympathetic nervous system activity in man
    Metabolism, 41 (2), 198-200
    PubMed 1736043
  8. Mitrakou A, Vuorinen-Markkola H, Raptis G, Toft I, Mokan M, Strumph P, Pimenta W, Veneman T, Jenssen T, Bolli G (1992)
    Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp
    J Clin Endocrinol Metab, 75 (2), 379-82
    DOI 10.1210/jcem.75.2.1639939, PubMed 1639939
  9. Uhlving S, Bergrem H, Gabrielsen K (1992)
    [Prevalence of diabetes in a 5-year material of amputations in Sør-Rogaland]
    Tidsskr Nor Laegeforen, 112 (3), 328-30
    PubMed 1553666

Publications 1991

  1. Bentdal OH, Fauchald P, Brekke IB, Holdaas H, Hartmann A (1991)
    Rehabilitation and quality of life in diabetic patients after successful pancreas-kidney transplantation
    Diabetologia, 34 Suppl 1, S158-9
    PubMed 1936685
  2. Berg KJ, Holdaas H, Endresen L, Fauchald P, Hartmann A, Pran T, Solbu D (1991)
    Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients
    Nephrol Dial Transplant, 6 (10), 725-30
    DOI 10.1093/ndt/6.10.725, PubMed 1836548
  3. Durrant JD, Gerich JE, Mitrakou A, Jenssen T, Hyre RJ (1991)
    Changes in BAEP under hypoglycemia: temperature-related?
    Electroencephalogr Clin Neurophysiol, 80 (6), 547-50
    PubMed 1720731
  4. Endresen L, Bergan S, Holdaas H, Pran T, Sinding-Larsen B, Berg KJ (1991)
    Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients
    Ther Drug Monit, 13 (6), 490-5
    DOI 10.1097/00007691-199111000-00004, PubMed 1837629
  5. Hartmann A, Charania B, Sund S, Holdaas H, Fauchald P, Flatmark A (1991)
    Interstitial nephritis with extensive calcium deposits as a cause of renal allograft failure
    Nephrol Dial Transplant, 6 (12), 984-8
    DOI 10.1093/ndt/6.12.984, PubMed 1798600
  6. Hartmann A, Holdaas H (1991)
    [Therapeutic principles in hyperkalemia]
    Tidsskr Nor Laegeforen, 111 (18), 2275-7
    PubMed 1896986
  7. Holdaas H, Brekke IB, Hartmann A, Fauchald P, Bentdal O, Søodal G, Jervell J, Flatmark A (1991)
    Long-term glucose control following combined kidney and pancreatic transplantation
    Transplant Proc, 23 (1 Pt 2), 1656-7
    PubMed 1989322
  8. Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg KJ (1991)
    Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy
    J Intern Med, 229 (2), 163-70
    DOI 10.1111/j.1365-2796.1991.tb00325.x, PubMed 1847721
  9. Holst N, Jenssen TG, Burhol PG, Haug E (1991)
    Prolactin response to secretin during the spontaneous menstrual cycle in women
    Gynecol Obstet Invest, 31 (1), 37-41
    DOI 10.1159/000293097, PubMed 1672662
  10. Holst N, Oian P, Aune B, Jenssen TG, Burhol PG (1991)
    Increased plasma levels of vasoactive intestinal polypeptide in pre-eclampsia
    Br J Obstet Gynaecol, 98 (8), 803-6
    DOI 10.1111/j.1471-0528.1991.tb13486.x, PubMed 1911589
  11. Midtvedt K (1991)
    [Measurement of C-reactive protein gives valuable information on patients with various types of inflammation]
    Tidsskr Nor Laegeforen, 111 (13), 1660-1
    PubMed 2063373
  12. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J (1991)
    Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction
    Am J Physiol, 260 (1 Pt 1), E67-74
    DOI 10.1152/ajpendo.1991.260.1.E67, PubMed 1987794

Publications 1990

  1. Bernersen B, Johnsen R, Straume B, Burhol PG, Jenssen TG, Stakkevold PA (1990)
    Towards a true prevalence of peptic ulcer: the Sørreisa gastrointestinal disorder study
    Gut, 31 (9), 989-92
    DOI 10.1136/gut.31.9.989, PubMed 2210467
  2. Brekke IB, Holdaas H, Albrechtsen D, Fauchald P, Flatmark A (1990)
    Combined pancreatic and renal transplantation: improved survival of uremic diabetic patients and renal grafts
    Transplant Proc, 22 (4), 1580
    PubMed 2389410
  3. Dahl O, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavli H, Thunold J (1990)
    Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway
    Cancer, 66 (11), 2286-94
    DOI 10.1002/1097-0142(19901201)66:11<2286::aid-cncr2820661106>3.0.co;2-t, PubMed 2245382
  4. Gerich JE, Mitrakou A, Kelley D, Mandarino L, Nurjhan N, Reilly J, Jenssen T, Veneman T, Consoli A (1990)
    Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM
    Diabetes, 39 (2), 211-6
    DOI 10.2337/diab.39.2.211, PubMed 2227129
  5. Holdaas H, Brekke IB, Hartmann A, Fauchald P, Berg KJ, Sødal G, Jervell J, Flatmark A (1990)
    Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up
    Transplant Proc, 22 (2), 655-6
    PubMed 2327010
  6. Holdaas H, Hartmann A, Talseth T, Fauchald P, Sødal G, Brekke IB, Berg KJ (1990)
    Change in intrarenal sodium reabsorption following donor nephrectomy
    Transplant Proc, 22 (1), 246
    PubMed 2309323
  7. Holst N, Jenssen TG, Burhol PG (1990)
    A characterization of immunoreactive somatostatin in human milk
    J Pediatr Gastroenterol Nutr, 10 (1), 47-52
    DOI 10.1097/00005176-199001000-00010, PubMed 1969941
  8. Holst N, Jenssen TG, Burhol PG, Haug E (1990)
    The effects of secretin on prolactin, estradiol, vasoactive intestinal polypeptide, and somatostatin levels in women
    Acta Endocrinol (Copenh), 122 (3), 313-8
    DOI 10.1530/acta.0.1220313, PubMed 1970210
  9. Madsen S, Midtvedt K (1990)
    [Penicillin in clinical use--50 years]
    Tidsskr Nor Laegeforen, 110 (30), 3884-7
    PubMed 2281453
  10. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J (1990)
    Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM
    Diabetes, 39 (11), 1381-90
    DOI 10.2337/diab.39.11.1381, PubMed 2121568
  11. Norstein J, Brekke IB, Holdaas H, Vatne K (1990)
    Arterial stenoses in duct occluded segmental pancreatic grafts treated with percutaneous transluminal angioplasty
    Transplant Proc, 22 (2), 599-601
    PubMed 2139263

Publications 1989

  1. Berg KJ, Gjellestad A, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T (1989)
    Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients
    Nephron, 53 (3), 218-22
    DOI 10.1159/000185747, PubMed 2677807
  2. Holdaas H, Brekke IB, Hartmann A, Talseth T, Sødal G, Jervell J, Flatmark A (1989)
    Long-term metabolic control in recipients of duct-occluded segmental pancreatic grafts
    Transplant Proc, 21 (1 Pt 3), 2854-5
    PubMed 2650384
  3. Holst N, Jenssen TG, Burhol PG, Haug E, Forsdahl F (1989)
    Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles
    J Clin Endocrinol Metab, 68 (6), 1160-6
    DOI 10.1210/jcem-68-6-1160, PubMed 2498386
  4. Holst N, Jenssen TG, Burhol PG, Maltau JM (1989)
    Plasma secretin concentrations during normal human pregnancy, delivery, and postpartum
    Br J Obstet Gynaecol, 96 (4), 424-7
    DOI 10.1111/j.1471-0528.1989.tb02416.x, PubMed 2751955
  5. Hvidsten D, Lindsetmo RO, Røkke O, Jenssen TG, Burhol PG, Revhaug A (1989)
    Clearance of vasoactive intestinal polypeptide (VIP) in the porcine pulmonary circulation
    Regul Pept, 26 (3), 267-75
    DOI 10.1016/0167-0115(89)90194-8, PubMed 2623191
  6. Johannessen JO, Bergrem H (1989)
    [Neuroleptic malignant syndrome]
    Tidsskr Nor Laegeforen, 109 (6), 696-7
    PubMed 2922736
  7. Tydén G, Brattström C, Bolinder J, Bohman SO, Groth CG, Brekke IB, Holdaas H, Flatmark A (1989)
    Long-term metabolic control in recipients of segmental-pancreas grafts with pancreaticoenterostomy or duct obstruction
    Diabetes, 38 Suppl 1, 94-6
    DOI 10.2337/diab.38.1.s94, PubMed 2642864

Publications 1988

  1. Almdahl SM, Jenssen TG, Samdal FA, Burhol PG (1988)
    The effect of pancreatectomy and gastroenterectomy on the release of somatostatin and vasoactive intestinal polypeptide in experimental fecal peritonitis
    Scand J Gastroenterol, 23 (1), 31-4
    DOI 10.3109/00365528809093843, PubMed 2894071
  2. Hartmann A, Holdaas H (1988)
    [Emergency treatment of serious hypertension]
    Tidsskr Nor Laegeforen, 108 (33), 3108-10
    PubMed 3206505
  3. Holdaas H, Hartmann A, Talseth T, Berg KJ, Fauchald P, Stenstrøm J, Djøseland O, Nordal KP, Brodwall E (1988)
    Short-term changes in renal function of the remaining kidney after donor nephrectomy
    Transplant Proc, 20 (3), 434-5
    PubMed 3381255
  4. Holdaas H, Talseth T, Berg KJ, Fauchald P, Nordal KP, Hartmann A (1988)
    Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis
    Transplant Proc, 20 (3), 423-4
    PubMed 3289174
  5. Holst N, Jenssen TG, Burhol PG, Jorde R (1988)
    Gastrointestinal regulatory peptides during oxytocin infusion in post-term pregnancies
    Acta Physiol Scand, 132 (1), 23-7
    DOI 10.1111/j.1748-1716.1988.tb08293.x, PubMed 2906209
  6. Revhaug A, Lygren I, Jenssen TG, Giercksky KE, Burhol PG (1988)
    Vasoactive intestinal peptide in sepsis and shock
    Ann N Y Acad Sci, 527, 536-45
    DOI 10.1111/j.1749-6632.1988.tb27007.x, PubMed 3291700
  7. Talseth T, Holdaas H, Albrechtsen D, Berg KJ, Fauchald P, Naalsund A, Nordal KP, Skar AG, Sødal G, Flatmark A (1988)
    Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients
    Transplant Proc, 20 (3), 400-1
    PubMed 3289169

Publications 1987

  1. Burhol PG, Jenssen TG, Florholmen J, Jorde R (1987)
    [Apudomas of the gastrointestinal tract and pancreas]
    Tidsskr Nor Laegeforen, 107 (7), 652-3, 672
    PubMed 3576560

Publications 1986

  1. Almdahl SM, Jenssen TG, Burhol PG, Giercksky KE (1986)
    Vasoactive intestinal polypeptide and somatostatin in experimental endogenous gram-negative peritonitis
    Acta Chir Scand, 152, 135-8
    PubMed 2869631
  2. Hartmann A, Langberg H, Holdaas H, Kiil F (1986)
    Glomerulotubular balance during renal sympathetic stimulation
    Acta Physiol Scand, 127 (2), 187-95
    DOI 10.1111/j.1748-1716.1986.tb07893.x, PubMed 2873711
  3. Holst N, Jenssen TG, Burhol PG, Jorde R, Maltau JM (1986)
    Plasma vasoactive intestinal polypeptide, insulin, gastric inhibitory polypeptide, and blood glucose in late pregnancy and during and after delivery
    Am J Obstet Gynecol, 155 (1), 126-31
    DOI 10.1016/0002-9378(86)90094-3, PubMed 3524233
  4. Holst N, Jenssen TG, Burhol PG, Jorde R, Maltau JM, Haug E (1986)
    Gut peptides in lactation
    Br J Obstet Gynaecol, 93 (2), 188-93
    DOI 10.1111/j.1471-0528.1986.tb07885.x, PubMed 2868752
  5. Hvidsten D, Jenssen TG, Bolle R, Burhol PG (1986)
    Plasma gastrointestinal regulatory peptides in exercise-induced asthma
    Eur J Respir Dis, 68 (5), 326-31
    PubMed 2874049
  6. Jenssen TG, Haukland HH, Florholmen J, Jorde R, Burhol PG (1986)
    Evidence of somatostatin as a humoral modulator of motilin release in man. A study of plasma motilin and somatostatin during intravenous infusion of somatostatin, secretin, cholecystokinin, and gastric inhibitory polypeptide
    Scand J Gastroenterol, 21 (3), 273-80
    DOI 10.3109/00365528609003076, PubMed 2872717
  7. Jenssen TG, Holst N, Burhol PG, Jorde R, Maltau JM, Vonen B (1986)
    Plasma concentrations of motilin, somatostatin and pancreatic polypeptide before, during and after parturition
    Acta Obstet Gynecol Scand, 65 (2), 153-6
    DOI 10.3109/00016348609158371, PubMed 2873707
  8. Jenssen TG, Revhaug A, Burhol PG, Giercksky KE, Vonen B (1986)
    Effect of haemorrhagic shock and duodenal instillation of blood on the plasma profiles of somatostatin and motilin in pigs. A study of molecular plasma components
    Scand J Gastroenterol, 21 (3), 281-90
    PubMed 2872718
  9. Riepl R, Jenssen TG, Revhaug A, Burhol PG, Gierchksky KE, Lehnert P (1986)
    [Increase of plasma cholecystokinin by Escherichia coli endotoxin-induced shock in swine]
    Z Gastroenterol, 24 (11), 691-9
    PubMed 3544541

Publications 1985

  1. Bergrem H, Jervell J, Flatmark A (1985)
    Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients
    Kidney Int, 27 (2), 459-64
    DOI 10.1038/ki.1985.31, PubMed 3887001
  2. Burhol PG, Jenssen TG, Florholmen J, Jorde R (1985)
    Protein-binding of secretin in human plasma
    Acta Physiol Scand, 123 (3), 339-47
    DOI 10.1111/j.1748-1716.1985.tb07598.x, PubMed 4061116
  3. Burhol PG, Jenssen TG, Schulz TB, Lygren I, Jorde R (1985)
    Production and evaluation of rabbit cholecystokinin (CCK)
    Mater Med Pol, 17 (1), 34-8
    PubMed 4033220
  4. Burhol PG, Jorde R, Florholmen J, Jenssen TG, Vonen B (1985)
    A systematic approach to the preparation of 125I-labeled gastrointestinal regulatory peptides with high specific radioactivities
    Scand J Gastroenterol, 20 (4), 466-9
    DOI 10.3109/00365528509089682, PubMed 2862690
  5. Burhol PG, Lygren I, Jenssen TG, Jorde R (1985)
    Diurnal profiles of plasma cholecystokinin (CCK) and vasoactive intestinal polypeptide (VIP) in man
    Mater Med Pol, 17 (1), 30-3
    PubMed 4040993
  6. Florholmen J, Burhol PG, Jenssen TG, Jorde R (1985)
    Pharmacological effects of gastric inhibitory polypeptide, cholecystokinin, and somatostatin on the serum levels of cationic trypsin-like immunoreactivity in man
    Scand J Gastroenterol, 20 (7), 829-34
    DOI 10.3109/00365528509088830, PubMed 2864738
  7. Holdaas H, Kopp UC, DiBona GF (1985)
    Modulation of reflex renal vasoconstriction by increased endogenous renal prostaglandin synthesis
    J Pharmacol Exp Ther, 232 (3), 725-31
    PubMed 3973825
  8. Jenssen TG, Burhol PG, Jorde R (1985)
    Release of gastrointestinal regulatory peptides after a soap enema
    Scand J Gastroenterol, 20 (6), 762-6
    DOI 10.3109/00365528509089210, PubMed 2863869
  9. Jenssen TG, Revhaug A, Burhol PG, Giercksky KE, Lygren I (1985)
    The origin and fall of plasma motilin during Escherichia coli endotoxin shock in pigs
    Acta Physiol Scand, 123 (4), 399-404
    DOI 10.1111/j.1748-1716.1985.tb07606.x, PubMed 3887842
  10. Midtvedt K, Midtvedt T (1985)
    Rapid determination of antibiotic susceptibility by a disc diffusion test for urgent clinical situations
    Scand J Infect Dis, 17 (1), 131-2
    DOI 10.3109/00365548509070435, PubMed 3992201
  11. Vikse A, Holdaas H, Sejersted OM, Kiil F (1985)
    Haemodynamic conditions for renal PGE2 and renin release during alpha- and beta-adrenergic stimulation in dogs
    Acta Physiol Scand, 124 (2), 163-72
    DOI 10.1111/j.1748-1716.1985.tb07648.x, PubMed 2861715

Publications 1984

  1. Burhol PG, Jenssen TG, Jorde R, Lygren I, Johnson JA (1984)
    Plasma cholecystokinin (CCK) before and after a jejunoileal bypass operation in obese patients with reference to appetite regulation
    Int J Obes, 8 (3), 233-6
    PubMed 6746190
  2. Burhol PG, Jorde R, Jenssen TG, Lygren I, Florholmen J (1984)
    Diurnal profile of plasma somatostatin in man
    Acta Physiol Scand, 120 (1), 67-70
    DOI 10.1111/j.1748-1716.1984.tb07374.x, PubMed 6144239
  3. Burhol PG, Lygren I, Jenssen TG, Florholmen J, Jorde R (1984)
    Somatostatin release and plasma molecular somatostatin components in man
    Acta Physiol Scand, 121 (3), 223-8
    DOI 10.1111/j.1748-1716.1984.tb07450.x, PubMed 6433648
  4. Hartmann A, Holdaas H, Steen PA, Kiil F (1984)
    Evidence for bicarbonate-dependent lithium reabsorption in dog kidneys
    Acta Physiol Scand, 120 (2), 257-64
    DOI 10.1111/j.1748-1716.1984.tb00132.x, PubMed 6231805
  5. Hartmann A, Langberg H, Holdaas H, Kiil F (1984)
    Glomerular filtration rate and PCO2 as determinants of lithium reabsorption
    Acta Physiol Scand, 121 (3), 283-90
    DOI 10.1111/j.1748-1716.1984.tb07458.x, PubMed 6089506
  6. Holdaas H, DiBona GF (1984)
    Stimulatory and inhibitory reflexes from somatic receptors: effect on renin release
    Am J Physiol, 246 (6 Pt 2), R1005-10
    DOI 10.1152/ajpregu.1984.246.6.R1005, PubMed 6377915
  7. Holdaas H, DiBona GF (1984)
    On the existence of renal vasodilator nerves
    Proc Soc Exp Biol Med, 176 (4), 426-33
    DOI 10.3181/00379727-176-41893, PubMed 6463053
  8. Jenssen TG, Burhol PG, Jorde R, Florholmen J, Lygren I (1984)
    Radioimmunoassayable plasma motilin in man. Secretagogues, insulin-induced suppression, renal removal, and plasma components
    Scand J Gastroenterol, 19 (6), 717-23
    PubMed 6393315
  9. Langberg H, Hartmann A, Holdaas H, Kiil F (1984)
    Site and magnitude of the tubular inhibitory effect of expanding the extracellular volume in dogs
    Acta Physiol Scand, 122 (3), 285-98
    DOI 10.1111/j.1748-1716.1984.tb07512.x, PubMed 6516881
  10. Langård O, Holdaas H, Vikse A, Sejersted OM, Eide I (1984)
    Ouabain inhibits renin release by a direct renal haemodynamic effect
    Scand J Clin Lab Invest, 44 (6), 557-63
    DOI 10.3109/00365518409083611, PubMed 6148785
  11. Lygren I, Revhaug A, Burhol PG, Giercksky KE, Jenssen TG (1984)
    Vasoactive intestinal polypeptide and somatostatin in leucocytes
    Scand J Clin Lab Invest, 44 (4), 347-51
    DOI 10.3109/00365518409083818, PubMed 6147010
  12. Vikse A, Holdaas H, Sejersted OM, Kiil F (1984)
    Relationship between PGE2 and renin release in dog kidneys. Effects of afferent arteriolar dilation and adrenergic stimulation
    Acta Physiol Scand, 121 (3), 261-8
    DOI 10.1111/j.1748-1716.1984.tb07455.x, PubMed 6382924

Publications 1983

  1. Bergrem H, Grøttum P, Rugstad HE (1983)
    Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration
    Eur J Clin Pharmacol, 24 (3), 415-9
    DOI 10.1007/BF00610064, PubMed 6861855
  2. Bergrem H, Jervell J, Flatmark A (1983)
    Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients
    Proc Eur Dial Transplant Assoc, 20, 286-90
    PubMed 6361740
  3. BERGREM H, JERVELL J, FLATMARK A (1983)
    DIFFERENT PREDNISOLONE PHARMACOKINETICS IN CUSHINGOID AND NON-CUSHINGOID KIDNEY-TRANSPLANT PATIENTS
    P EUR DIAL TRANS, 20, 286-290
  4. Bergrem H, Opedal I (1983)
    Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding
    Scand J Gastroenterol, 18 (4), 545-9
    DOI 10.3109/00365528309181635, PubMed 6669930
  5. Bergrem H, Refvem OK (1983)
    Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin
    Proc Eur Dial Transplant Assoc, 19, 552-7
    PubMed 6878255
  6. Bergrem H, Refvem OK (1983)
    Altered prednisolone pharmacokinetics in patients treated with rifampicin
    Acta Med Scand, 213 (5), 339-43
    PubMed 6880856
  7. Bergrem H, Ritland S, Opedal I, Bergan A (1983)
    Prednisolone pharmacokinetics and protein-binding in patients with portosystemic shunt
    Scand J Gastroenterol, 18 (2), 273-6
    DOI 10.3109/00365528309181594, PubMed 6673058
  8. Holdaas H (1983)
    Adrenergic control of renin release
    J Oslo City Hosp, 33 (10-11), 111-27
    PubMed 6315904
  9. Langård O, Holdaas H, Eide I, Kiil F (1983)
    Conditions for augmentation of renin release by theophylline
    Scand J Clin Lab Invest, 43 (1), 9-14
    PubMed 6312554
  10. Osborn JL, Holdaas H, Thames MD, DiBona GF (1983)
    Renal adrenoceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog
    Circ Res, 53 (3), 298-305
    DOI 10.1161/01.res.53.3.298, PubMed 6349846
  11. Vikse A, Holdaas H, Hartmann A, Kiil F (1983)
    Segmental distribution of vascular resistances during ureteral occlusion. The vasoconstrictive effects of angiotensin and CaCl2 differ from those of catecholamines and renal nerve stimulation
    Acta Physiol Scand, 119 (2), 147-58
    DOI 10.1111/j.1748-1716.1983.tb07320.x, PubMed 6140816
  12. Vikse A, Holdaas H, Sejersted OM, Eide I, Kiil F (1983)
    Prostaglandin E2 and renin release response to dilation of afferent arterioles and during alpha- and beta-adrenergic stimulation
    Acta Med Scand Suppl, 677, 44-7
    PubMed 6322531

Publications 1982

  1. Bergrem H, Jervell J, Solheim DM, Flatmark A (1982)
    Prognostic value of renal vein renin determination in suspected renovascular hypertension
    Acta Med Scand, 211 (5), 387-91
    PubMed 6126071
  2. BERGREM H, REFVEM OK (1982)
    CHANGES IN PREDNISOLONE PHARMACOKINETICS AND PROTEIN-BINDING DURING TREATMENT WITH RIFAMPICIN
    P EUR DIAL TRANS, 19, 552-557
  3. Burhol PG, Jenssen TG, Lygren I, Schulz TB, Jorde R, Waldum HL (1982)
    Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man
    Digestion, 23 (3), 156-68
    DOI 10.1159/000198723, PubMed 7106417
  4. Holdaas H, Langaard O, Eide I, Kiil F (1982)
    Conditions for enhancement of renin release by isoproterenol, dopamine, and glucagon
    Am J Physiol, 242 (3), F267-73
    DOI 10.1152/ajprenal.1982.242.3.F267, PubMed 7039349
  5. Midtvedt T, Midtvedt K (1982)
    Sport and infection
    Scand J Soc Med Suppl, 29, 241-4
    PubMed 6958046
  6. MIDTVEDT T, MIDTVEDT K (1982)
    SPORT AND INFECTION
    Scand. J. Soc. Med. (29), 241-244

Publications 1981

  1. BERGREM H, DJOSELAND O, JERVELL J, RUGSTAD HE (1981)
    ABSORPTION OF PREDNISOLONE .1. THE EFFECT OF FASTING, FOOD, AND FOOD COMBINED WITH ANTACIDS
    Scand. J. Urol. Nephrol. (64), 167-173
  2. Bergrem H, Djøseland O, Jervell J, Rugstad HE (1981)
    Immunosuppressive treatment policies. A) Glucocorticoids: absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids
    Scand J Urol Nephrol Suppl, 64, 167-73
    PubMed 6959258
  3. BERGREM H, JAKOBSEN A, FLATMARK A (1981)
    PREDNISOLONE IN RENAL-TRANSPLANTATION - A COMPARISON BETWEEN 2 DOSAGE REGIMES
    Scand. J. Urol. Nephrol. (64), 174-178
  4. Bergrem H, Jakobsen A, Flatmark A (1981)
    Prednisolone in renal transplantation: a comparison between two dosage regimes
    Scand J Urol Nephrol Suppl, 64, 174-8
    PubMed 6755677
  5. Holdaas H, DiBona GF, Kiil F (1981)
    Effect of low-level renal nerve stimulation on renin release from nonfiltering kidneys
    Am J Physiol, 241 (2), F156-61
    DOI 10.1152/ajprenal.1981.241.2.F156, PubMed 7023249
  6. Holdaas H, Langård O, Eide I, Kiil F (1981)
    Mechanism of renin release during renal nerve stimulation in dogs
    Scand J Clin Lab Invest, 41 (7), 617-25
    DOI 10.3109/00365518109090506, PubMed 7041238
  7. Jenssen TG, Waldum HL, Burhol PG, Straume BK (1981)
    [The diagnosis of peptic ulcer and gastric cancer in gastroscopy case material]
    Tidsskr Nor Laegeforen, 101 (12), 706-9
    PubMed 7245155
  8. Jorde R, Burhol PG, Schulz TB, Waldum HL, Lygren I, Jenssen T, Myhre ES (1981)
    The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man
    Scand J Gastroenterol, 16 (1), 109-12
    PubMed 7015476
  9. Jorde R, Waldum HL, Burhol PG, Lygren I, Schulz TB, Florholmen J, Jenssen TG (1981)
    The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man
    Scand J Gastroenterol, 16 (1), 113-9
    PubMed 6112787
  10. Langberg H, Mathisen O, Holdaas H, Kiil F (1981)
    Filtered bicarbonate and plasma pH as determinants of renal bicarbonate reabsorption
    Kidney Int, 20 (6), 780-8
    DOI 10.1038/ki.1981.211, PubMed 6801371
  11. Langård O, Holdaas H, Eide I, Kiil F (1981)
    Conditions for stimulation of renin release by cyclic AMP in anaesthetized dogs
    Scand J Clin Lab Invest, 41 (6), 535-42
    DOI 10.3109/00365518109090495, PubMed 6278577
  12. Langård O, Holdaas H, Eide I, Kiil F (1981)
    Conditions for humoral alpha-adrenoceptor stimulation of renin release in anaesthetized dogs
    Scand J Clin Lab Invest, 41 (6), 527-34
    DOI 10.3109/00365518109090494, PubMed 6278576
  13. PAPE J, JERVELL J, ANKER E, BERGREM H, DAHLE K, LEIVESTAD T, MYRSETH L, THAULOW E, URVING H, VANDERLIPPE A (1981)
    BLOOD-PRESSURE AND PULSE RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA DURING NON-SELECTIVE AND SELECTIVE BETA-BLOCKADE
    Acta Med. Scand. (645), 105-108
  14. Pape J, Jervell J, Anker E, Bergrem H, Dahle K, Leivestad T, vd Lippe A, Myrseth L, Thaulow E, Urving H (1981)
    Blood pressure and pulse response to insulin-induced hypoglycemia during non-selective and selective beta-blockade
    Acta Med Scand Suppl, 645, 105-8
    PubMed 6112844

Publications 1980

  1. Bergrem H, Jervell J, Brodwall EK, Flatmark A, Mellbye O (1980)
    Goodpasture's syndrome. A report of seven patients including long-term follow-up of three who received a kidney transplant
    Am J Med, 68 (1), 54-8
    DOI 10.1016/0002-9343(80)90165-5, PubMed 6985766
  2. Midtvedt T, Midtvedt K (1980)
    [Athletics and infections]
    Tidsskr Nor Laegeforen, 100 (12B), 859-62
    PubMed 7404535
  3. Røyset PM, Jenssen TG, Burhol PG (1980)
    [Crohn's disease. Tromsø-material from the period 1974-1978]
    Tidsskr Nor Laegeforen, 100 (16), 1068-70
    PubMed 7414587

Publications 1979

  1. Jenssen TG, Røyset P, Burhol P (1979)
    [Ulcerative colitis. A Tromsø series, 1974-1977]
    Tidsskr Nor Laegeforen, 99 (3), 149-52
    PubMed 419493
  2. Mathisen O, Holdaas H, Kiil F (1979)
    Re-examination of the dose-reponse relationship for the renal effect of acetozolamide
    Scand J Clin Lab Invest, 39 (4), 297-301
    DOI 10.3109/00365517909106112, PubMed 523981
  3. Mathisen O, Monclair T, Holdaas H, Kiil F (1979)
    To what extent does acetazolamide inhibit renal bicarbonate reabsorption?
    Scand J Clin Lab Invest, 39 (4), 293-5
    DOI 10.3109/00365517909106111, PubMed 118512

Publications 1978

  1. Bergrem H, Flatmark A, Simonsen S (1978)
    Dialysis fistulas and cardiac failure
    Acta Med Scand, 204 (3), 191-3
    PubMed 696419
  2. Bergrem H, Leivestad T (1978)
    Dialysis death and increased free fatty acids
    Lancet, 2 (8100), 1160
    DOI 10.1016/s0140-6736(78)92328-0, PubMed 82729
  3. Bohmer T, Bergrem H, Eiklid K (1978)
    Carnitine deficiency induced during intermittent haemodialysis for renal failure
    Lancet, 1 (8056), 126-8
    DOI 10.1016/s0140-6736(78)90422-1, PubMed 87556
  4. Mathisen O, Monclair T, Holdaas H, Kiil F (1978)
    Bicarbonate as mediator of proximal tubular NaCl reabsorption and glomerulotubular balance
    Scand J Clin Lab Invest, 38 (1), 7-17
    DOI 10.3109/00365517809108396, PubMed 415348
  5. Sejersted OM, Holdaas H, Monclair T (1978)
    Functional differences of ouabain and ethacrynic acid on renal potassium metabolism in dogs
    Scand J Clin Lab Invest, 38 (7), 603-14
    DOI 10.3109/00365517809102426, PubMed 152453

Publications 1977

  1. BOHMER T, BERGREM H, EIKLID K (1977)
    CARNITINE DEFICIENCY INDUCED DURING INTERMITTENT HEMODIALYSIS FOR RENAL-FAILURE
    Lancet, 1 (8056), 127-128

Publications 1968

  1. Poulsen PA, Norby G, Esmann V (1968)
    [Purulent meningitis. A survey of 270 patients from the period 1938-1967]
    Nord Med, 79 (16), 519-23
    PubMed 5657637

Publications 1966

  1. Petersen ES, Norby G (1966)
    A comparison between two techniques of smallpox vaccination
    Dan Med Bull, 13 (6), 168-9
    PubMed 5927702

Publications 1959

  1. POULSEN PA, NORBY G (1959)
    Tetanus: An analysis of 40 cases treated during the period 1939-1959
    Dan Med Bull, 6, 223-7
    PubMed 14434515

Publications 1955

  1. BASTRUP-MADSEN P, NØRBY G (1955)
    Pneumococcal meningitis; mastoidectomy adjunctive to antibiotic treatment
    Acta Med Scand, 151 (2), 135-49
    PubMed 14349632

Publications 1952

  1. BASTRUP-MADSEN P, NØRBY G (1952)
    [Antibiotic therapy of staphylococcus septicemia]
    Nord Med, 47 (7), 201-3
    PubMed 14910973
  2. NØRBY G (1952)
    [Hemoculture]
    Nord Med, 47 (7), 224
    PubMed 14910983

 
Page visits: 2783